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ABSTRACT 
Intermediate filament keratins (K) play a pivotal role in protein targeting and epithelial 
cytoprotection from stress as evidenced by keratin mutations predisposing to human 
liver and skin diseases and possibly inflammatory bowel disease (IBD). The K8-null 
(K8-/-) mice exhibit colonic phenotype similar to IBD and marked spontaneous colitis, 
epithelial hyperproliferation, decreased apoptosis, mistargeting of proteins leading to 
defective ion transport and diarrhea. The K8-heterozygote (K8+/-) mouse colon appears 
normal but displays a defective sodium (Na+) and chloride (Cl-) transport similar to, 
but milder than K8-/-.  
Characterization of K8+/- colon revealed ~50% less keratins (K7, K8, K19, K20) 
compared to K8 wild type (K8+/+). A similar ~50% decrease was seen in K8+/- mRNA 
levels as compared to K8+/+, while the mRNA levels for the other keratins were 
unaltered. K8+/- keratins were arranged in a normal colonic crypt expression pattern, 
except K7 which was expressed at the top of crypts in contrast to K8+/+. The K8+/- 
colon showed mild hyperplasia but no signs of inflammation and no resistance to 
apoptosis. Experimental colitis induced by using different concentrations of dextran 
sulphate sodium (DSS) showed that K8+/- mice are slightly more sensitive to induced 
colitis and showed a delayed recovery compared to K8+/+. Hence, the K8+/- mouse with 
less keratins and without inflammation, provided a novel model to study direct 
molecular mechanisms of keratins in intestinal homeostasis and ion transport.  
Different candidate ion transporters for a possible role in altered ion transport seen in the 
K8-/- and K8+/- mouse colon were evaluated. Besides normal levels of CFTR, PAT-1 and 
NHE-3, DRA mRNA levels were decreased 3-4-fold and DRA protein nearly entirely lost 
in K8-/- caecum, distal and proximal colon compared to K8+/+. In K8+/- mice, DRA mRNA 
levels were unaltered while decreased DRA protein level and patchy distribution was 
detected particularly in the proximal colon and as compared to K8+/+. DRA was similarly 
decreased when K8 was knocked-down in Caco-2 cells, confirming that K8 levels 
modulate DRA levels in an inflammation-independent manner. The dramatic loss of DRA 
in colon and caecum of K8-/- mice was responsible for the chloride transport defect. The 
milder ion transport in K8+/- colon might be related to DRA suggesting a role for K8 in 
regulation of DRA expression and targeting. The current study demonstrates the 
importance of keratins in stress protection and cell signaling.  
Furthermore, we have also successfully developed a novel, simple, fast, cost effective, 
non-invasive in vivo imaging method for the early diagnosis of murine colitis with 
specificity for both genetic and experimental colitis. The said modality provides 
continuous measurements of reactive oxygen and nitrogen species (RONS) and 
minimizes the use of an increased number of experimental animals by using a luminal 
derivative chemiluminescent probe, L-012 which provides a cost-effective tool to study 
the level and longitudinal progression of colitis.  
Key words: Intermediate filaments, Keratin 8, inflammatory bowel disease, colon, 
colitis, stress protection, ion transport, DRA, L-012, in vivo imaging, reactive oxygen 
and nitrogen species. 
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K8 keratin 8 
LP lamina propria 
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TPA tissue polypeptide antigen 
TPS tissue polypeptide specific antigen 
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-/- knock out 
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1. INTRODUCTION 
Keratins (K) are intermediate filament (IF) cytoskeletal proteins found in all epithelia 
of the body including the single layer of epithelial cells forming a barrier towards the 
intestinal lumen and are known for their role in cellular integrity, cell signaling, protein 
targeting, apoptosis and protection against stress. Simple epithelial keratins (SEK) of 
type II (K7, K8) and type I (K18, K19, K20, K23) compose the main IF cytoskeleton 
of intestinal epithelial cells (IECs). Keratins form obligate heteropolymers (one type I 
and one type II keratin) and share a common structure that consists of a central coiled-
coil α-helical rod domain that is flanked by non-α-helical head and tail domains. One 
of the major challenges in modern biomedicine is to explore the functional significance 
of keratins in intestine as specific keratin pairs predominate in an epithelial cell and 
differentiation state selective manner. The usefulness of keratins is obvious by the 
keratin mutations predisposing to human skin and liver disease and multiple mouse 
models phenocopying these diseases. Mutations in the genes encoding IF proteins 
either directly cause or predispose their carriers to more than 80 human diseases. 
Keratin mutations are found in ~ 10% of patients with liver disease, however, the 
correlation is still unclear in intestinal epithelia, although a few IBD patients with 
keratin mutations have been reported. Although the role of keratins in the intestine is 
not fully understood, it has been shown that K8 null (K8-/-) mice have epithelial 
hyperproliferation, decreased apoptosis and develop a Th2-type ulcerative colitis (UC) 
which is amendable to antibiotic treatment. The K8-/- mice also display a dramatic 
alteration in ion transport, leading to chloride secretion (rather than uptake) likely 
caused by epithelial ion transporter mistargeting, leading to diarrhea. Interestingly, the 
K8 heterozygote mice (K8+/-), which express lower K8 levels as compared to the K8 
wild type mice, also display an altered ion transport although no histological 
abnormalities are observed. This led us to hypothesize that the concentration of 
colonocyte keratin, or an intact keratin network, is essential to protect from colitis. The 
first aim of this PhD thesis is to characterize the K8+/- phenotype and to test the 
susceptibility of the K8+/- mice with lower levels of keratins in response to stress, i.e. 
experimental dextran sulphate sodium (DSS) colitis. 
The colon is responsible for the absorption of sodium (Na+), chloride (Cl-), potassium 
(K+), short chain fatty acids (SCFAs) and fluid, as well as to secrete bicarbonates 
(HCO3-) and mucus. The osmotic gradient created by salt transport using ion 
transporters and channels is the driving force for passive water movement in/out of 
the lumen. Water transport can also occur through specific water channels, the 
aquaporins. The colonic crypts are responsible for absorptive functions but may 
perform secretory functions such as in response to cholera toxin. Diarrhea results in 
electrolyte secretion and loss of fluid into intestinal lumen. An inflamed small 
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intestine fails to absorb food and results in secretion of water and salts into the 
alimentary canal. The colon cannot absorb this extra water which leads to diarrhea. 
Although the exact mechanism is not known, the K8-/- colon shows mistargeting of 
membrane transporters and altered Na+ and Cl- transport leading to diarrhea, which 
precedes hyperproliferation and inflammation. The K8-/- distal colon has normal tight 
junctions and paracellular transport besides having a decrease in short circuit current 
and net Na+ absorption associated with net Cl- secretion. The second aim of this 
thesis is to find out whether keratins are involved in ion transport and how intestinal 
keratins contribute to the intestinal phenotype and diarrhea.  
As use of experimental models for colitis as well as genetic models involves invasive 
techniques which are skill-requiring, time consuming and laborious, in vivo imaging 
would provide early and noninvasive diagnosis of colitis. Such methods had not been 
established. L-012 is a promising simple, cost effective chemiluminescent probe with 
high sensitivity against reactive oxygen and nitrogen species. L-012 is well distributed 
in the mouse body and mediates a strong ROS/RNS-dependent luminescent signal in 
vivo and is useful for monitoring the development and regulation of inflammation in 
living organisms. 
The thesis work provides an understanding about the roles of keratins, particularly of 
K8, in normal intestinal homeostasis and during colitis. Our results show that the levels 
of keratins matter for protection from stress and leads to the reduced levels of chloride 
transporter, downregulated in adenoma (DRA), in response to K8 ablation. These 
findings eventually provide a platform for further mechanistic studies to target direct 
molecular mechanisms of keratins in intestinal homeostasis including ion transport by 
using a K8+/- mouse as a novel model that lacks the inflammatory component and has 
lower levels of keratins. This thesis also claims significance for understanding human 
intestinal diseases which are possibly linked to keratin mutations. The thesis also 
focuses on the establishment of a novel in vivo imaging modality of murine colitis. The 
outcome of the research may, thus, also be helpful for future development of 
diagnostics and treatment of colitis.  
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2. REVIEW OF THE LITERATURE 
2.1. Overview of the intermediate filaments 
The eukaryotic cytoskeleton is composed of three major protein families, i.e. 
microfilaments (MFs), microtubules (MTs) and intermediate filaments (IFs) which can 
be differentiated from each other on the basis of their size (Fuchs and Coulombe, 1992; 
Ku et al., 1999; Lazarides, 1980; Steinert and Parry, 1985). Historically the name IFs 
was given because of the fact that these filaments have an average diameter of 10 nm 
which is greater than 7 nm of MFs and less than 25 nm MTs (Fuchs and Coulombe, 
1992; Omary et al., 2009). MFs and MTs are comprised of highly conserved proteins, 
actin and tubulin, respectively and are far more widespread in expression profiles 
(Eriksson et al., 2009; Ku et al., 1999; Moll et al., 1982b). In contrast, the diverse 
family of IF protein is formed by the transcription of 70 functional genes with 
alternative splicing and post-transcriptional modifications (Omary et al., 2009; 
Szeverenyi et al., 2008). Another differentiating feature of IFs is that, unlike MFs 
(actin) and MTs (tubulin), they are not composed of  globular proteins  (Table 1).  
2.1.1. Classification of intermediate filaments 
IF proteins are expressed in a tissue- and cell compartment-specific manner (Fuchs and 
Coulombe, 1992; Hesse et al., 2001; Lazarides, 1982; Omary et al., 2009) and can be 
divided into 6 major types based on similarities in central rod domain amino acid 
sequences, net acidic charge, and secondary structure predictions (Fig. 1). Most IF 
types are cytoplasmic (I-IV) while one type (V) is nuclear and consists of the lamins. 
The 6th class of IF proteins, also referred to as orphans, consists of the beaded filament 
structural protein 1 (Bfsp1; also known as filensin) and Bfsp2 (also known as phakinin 
and CP49), form highly specialized IFs found only in the lens of the eye. IFs can make 
homo- or hetero- polymers and can be further subdivided into three assembly groups 
on the basis of their abilities to copolymerize with each other. The type I cytoskeletal 
IF proteins are the acidic keratin proteins, and type II cytoskeletal IF proteins are the 
neutral-basic keratin proteins. At least one type I keratin and one type II keratin are 
needed to form heteropolymeric keratin IFs. Type III IF proteins, which include 
vimentin and desmin, can form homopolymeric IFs as well as heteropolymeric IFs in 
combination with other type III or type IV IFs. The type IV IF proteins include nestin, 
synemin and  neurofilament (NF) triplet proteins with low-, middle-, and high- 
molecular weight NF subunits i.e. NF-L, NF-M and NF-H. (Eriksson et al., 2009; 
Perng et al., 2007; Song et al., 2009; Steinert, 1998; Szeverenyi et al., 2008; Toivola et 
al., 2005). 
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Table 1. The main aspects of cytoskeletal elements. Adapted from on (Coulombe and Omary, 
2002; Ku et al., 1999; Toivola et al., 2005; Vartiainen, 2008).  
2.1.2. Main IF functions and IF-pathies 
IFs have been shown to play an important role in cell signaling, protein targeting and to 
perform cytoprotective functions. They facilitate cells to cope with mechanical and 
non-mechanical stresses. The mechanical stresses can include shear stress and 
compression of cells, while non-mechanical stresses are heat, metabolic, oxidative and 
genetic stresses (Toivola et al., 2005). IFs regulate the enzymatic activity of 
intracellular kinases by acting as a scaffold (Eriksson et al., 2009). Around 100 human 
diseases have been related to IFs (Szeverenyi et al., 2008) (Human intermediate 
filament database; www.interfil.org). IF disorders directly involved in disease 
manifestation are called IF-pathies including skin and hair diseases, myopathies, 
neurodegenerative disorders and cataracts (Omary et al., 2009). Missense mutations in 
conserved amino acid sequences of the α-helical domain either cause or predispose to 
human disease (Omary et al., 2009). Another leading cause of IF-pathies is formation 
of cell specific inclusion bodies which are indirectly involved in disease progress and 
serve as hallmarks for the diseases (Omary et al., 2004). Mutations in IF coding genes 
result in several human disorders and diseases, such as epidermolysis bullosa simplex 
(EBS), an inherited skin blistering disorder caused by mutation in K5/K14 (Bolling et 
al., 2011). Similarly, mutations in the genes encoding glial fibrillary acidic protein 
(GFAP) and peripherin result in Alexander’s disease (Brenner and Messing, 2014) and 
Properties Microfilaments Microtubules Intermediate filaments 
Prototype proteins Actins Tubulins Many, cell, tissue specific 
Expression Eukaryotes Eukaryotes Eukaryotes (besides yeast) 
Polarity + + - 
Solubility +++ +++ + 
Structure Conserved Conserved 
Diverse 
(with conserved 
subdomains) 
Diameter (nm) 5-8 25 10-12 
Phosphorylation + + ++++ 
Cellular location Cytoplasm, Nucleus Cytoplasm Cytoplasm, Nucleus 
Associated diseases + - ++++ 
Stress protection - - +++ 
Stabilizers Phalloidin Taxol Taxol 
Destabilizers Cytochalasins Colchicine  and others - 
Binding proteins +++ +++ + 
Specific functions Cell movement, attachment 
Cell cycle, 
intracellular transport - 
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several progressive neurological disorders (Corrado et al., 2011) respectively. The 
majorities of the IF-pathies are rare or orphan diseases with very little prevalence, i.e. 
less than 200,000 patients are living with this diseases in the US. (Office of Rare 
Diseases Research, http://rarediseases.info.nih.gov/RareDiseaseList.aspx). However, 
there are some exceptions, like the mutations in the genes encoding K8, K18, and K19 
that predispose individuals to progression of common chronic liver diseases including 
Hepatitis C (HCV) (Ku et al., 2007). IFs are broadly used in diagnostics and disease 
activity evaluation besides serving as autoantigens and markers for tumors, tissues and 
apoptotic and necrotic processes (Omary et al., 2009). The finding that IFs play a role 
in human diseases has helped in understanding IF functions in homeostasis. There is a 
need for further studies to explore IF functions by using animal models, in vitro models 
and human specimens.  
2.2. Keratins  
Keratins are the largest sub group of cytoplasmic IF proteins and form obligate non 
covalent heteropolymers consisting of type I and type II proteins, exclusively 
expressed in epithelial cells (Coulombe and Omary, 2002; Moll et al., 2008). However, 
some non-epithelial neoplasm and mesenchymal tissues such as heart may express low 
levels of keratins under certain circumstances (Papathanasiou et al., 2015). 
2.2.1. Keratin nomenclature and structure 
The human genome contains 54 functional keratin genes (KRT) at 12q13.13 and 
17q21.2 chromosomal sites. The KRT gene products are designated as ‘K’ followed by 
a number like K8, K18, K20 (Schweizer et al., 2006). Moll et al. (1982) proposed the 
first nomenclature of keratins based on two-dimensional gel electrophoresis separation 
and it has been repeatedly updated in recent years (Hesse et al., 2001; Hesse et al., 
2004; Schweizer et al., 2006). The novel consensus nomenclature of keratins is based 
according to the Human and Mouse Genome Nomenclature Committees guidelines 
(Schweizer et al., 2006) and is an revision of older nomenclatures. Szeverenyi et al. 
(2008) published a comprehensive catalogue of the human keratins, their amino acid 
sequence and the nucleotide sequence of the keratin genes in humans as well as in 
various vertebrate species. Keratins can be divided into acidic type and basic to neutral 
type on the basis of their isoelectric point which is defined as a pH value at which  
the net charge of a protein is 0. Based on nucleotide sequence, human keratins are 
classified into two types: 28 type I keratin genes (17 epithelial and 11 hair keratins) 
and 26 type II keratin genes (20 epithelial and 6 hair keratins) (Schweizer et al., 2006). 
Although IF proteins have quite distinct primary amino acid sequences, they share a 
common tripartite domain organization (Fig.2) and are major components of the 
mammalian cytoskeleton (Herrmann et al., 2009; Hesse et al., 2007; Kreplak et al., 
Review of the Literature 
 
16 
2004; Portet et al., 2009; Smith and Parry, 2007). The keratin polymer central α-helix 
rod domain contains around 310 amino acid residues and is flanked by a non-helical C-
terminal head and an NH2-terminal tail, varying in amino acid number. The molecular 
weight of keratins varies between 44 and 66 kDa (Herrmann et al., 2009; Moll et al., 
2008). It is well known that type I and type II keratins may form a functional polymer 
(usually tetramer) by combining in 1:1 ratio (Fig. 2). 
 
Figure 1. Tissue-and differentiation-dependent expression of intermediate filaments. IFs 
are expressed in a tissue-and differentiation-dependent manner. Epidermal keratins like K4/K13 
are expressed in the esophagus, K20 in suprabasal enterocytes. Type I (K7, K8) and Type 2 
(K18, K19, K20) simple epithelial keratins are expressed in simple epithelia such as the liver 
and intestine, vimentin is highly expressed in the vasculature and other resident mesenchymal 
cells. Similarly, desmin is expressed in the smooth muscle cells and NFs are expressed in the 
central and enteric nervous system. Lamins are expressed in the nucleus. Modifed from (Omary 
et al., 2009; Toivola et al., 2005).  
Lens 
Bfsp1 (VI) 
Bfsp2 (VI) 
Vimentin (III) 
Epidermal keratins 
K1, K2, K5, K6 (II) 
K9, K10, K14-K17, 
K19 (I) 
Simple epithelial 
keratins  
K7, K8 (II) 
K18-K20, K23 (I) 
Hair, hair follicle 
 K71-K86 (II)   
K25-K28, K31-K40 (I) 
Nervous System 
Neurofilaments NFH, 
NFL, NFM (IV), α-
internexin (IV), 
Nestin (IV), Peripherin 
(III), GFAP (III) 
Muscle (cardiac, 
skeletal, smooth) 
Desmin (III) 
Syncoloin (III) 
Synemin (IV) 
Nucleus 
Lamin A/C (V) 
Lamin B1, B2 (V) 
Blood vessel/ 
other 
mesenchyme 
Vimentin (III) 
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Table 2. IF protein expression in specific cells/tissues and related diseases. [adapted from 
(Omary et al., 2009; Snider and Omary, 2014; Zupancic et al., 2014)]. 
IF 
protein 
type 
Location Proteins Expression Diseases 
I, II Cytoplasm K1-K28, K31-K40 
and K71-K86 
Epithelia and epidermal 
appendages 
Several skin, 
nail, eye, liver, 
intestine and hair 
disorders 
I, II Cytoplasm  K7, K15, K20 Epithelia and epidermal 
appendages 
Unknown 
III Cytoplasm  Vimentin 
GFAP 
Desmin 
Syncolin 
Peripherin 
Mesenchymal cells and 
lens 
Astroctyes 
Muscle 
Muscle 
Peripheral nervous 
system 
Cataract 
Alexander 
disease 
Myopathies 
Unknown 
ALS 
IV Cytoplasm  Neurofilaments 
Α-Internexin 
Nestin 
Sysnemin 
Central nervous system 
Central nervous system 
Neuroepithelial cells 
Muscle 
ALS and CMT 
Unknown 
Unknown 
Unknown 
V Nucleus Lamins Nuclear Lamina Laminopathies 
VI Eye lens  Bfsp1 and Bfsp2 Fiber cells Cataract 
ALS, amytrophic lateral sclerosis; Bfsp, beaded filament structural protein: CMT, Charcot-
Marie-Tooth. 
Generally the head domain is involved in IF dimerization. It is a 20-amino acid 
fragment located in the front of coil 1A, which forms the α-helix and coiled-coil 
structure. Two antiparallel orientated coiled-coil dimers form a tetrameric IF building 
block which together take part in further assembling of IFs. Eight tetrameric subunits 
associate laterally to form unit-length filaments (ULFs) which anneal with other ULFs 
to give rise to a compact keratin filament (Fig. 3, (Herrmann et al., 2009).  
2.2.2. Simple Epithelial Keratins (SEK) with unique tissue and cell specific 
expression 
Keratins are highly conserved cytoplasmic IF proteins and expressed both in a cell-
lineage and tissue specific manner. Epithelial keratins are disseminated within two 
different types of epithelium as non-stratified simple epithelia and stratified squamous 
epithelia. The keratins which are expressed in non-stratified epithelia are loosely 
distributed within the cytoplasm and are called simple epithelial keratins (SEK). On the 
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other hand, the epidermis-type keratins or keratinocyte-type keratins are expressed 
within several  layers and are densely bundled filaments (tonofilaments) (Moll et al., 
2008). There are clear differences between epidermal, simple-type epithelial and hair 
keratins in amino acid sequences (Strnad et al., 2012b). Keratins are obligate non-
covalent heteropolymers which are composed of one type I and one type II keratin 
monomer (Moll et al., 2008; Omary et al., 2009). Simple epithelial keratins (SEKs) are 
found primarily in single-layered simple epithelia and include K7, K8, K18-K20, and 
K23. All SEK compose the IF cytoskeleton of IECs, where K23 is a recently described 
keratin the function of which is still unclear (Zhang et al., 2001).  K8/K18 and K8/K19 
are the most commonly co-expressed pairs and constitute the primary keratin pairs of 
simple epithelial cells. K8/K18 are the only IFs in hepatocytes while K8/K19 are the 
major SEKs in the colon. They are frequently found in highly specialized epithelia 
including hepatocytes, acinar cells of the pancreas, proximal tubular epithelial cells of 
the kidney and endocrine cells such as pancreatic islet cells along with K7, K19 and 
K20 (Franke et al., 1981; Moll et al., 1982a; Owens and Lane, 2003). Interestingly, 
primary and secondary keratins differ considerably in their distribution within distinct 
subcellular compartments. For example, K8 and K18 are found within cytoplasmic 
filaments in the pancreas, whereas K7 and K19 are localized in the apico-lateral 
compartment of the cell (Toivola et al., 2000a).  
 
Figure 2. Tripartite domain structure of Ks. Like other IF proteins, Ks are composed of an α-
helical central rod flanked by variable N-terminal head and C-terminal tail domains. The head 
and tail domains are enriched with sites for posttranslational modifications, phosphorylation (P) 
and glycosylation (G). The rod is formed by coils 1A, 1B and 2A, 2B separated from each other 
by linkers L1, L12 and L2. The L12 region of rod domain of type I but not type II keratins 
contains highly conserved caspase cleavage sites. For instance, type II keratin, K18, has two 
caspase digestion sites, i.e. VEVD and DALD in the L12 region and tail domain respectively. 
Based on this structure, IF proteins can form either homopolymers, as in desmin and vimentin, 
or obligate heteropolymers as in type I and II keratins. Modified from (Omary et al., 2009).  
Tripartite domain structure 
Highly conserved 
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Figure 3. Model summarizing current concepts of keratin intermediate filament assembly. 
Helix boundary peptides colored red (helix initiation motif) and silver (helix termination motif). 
A keratin heterodimer is composed of keratin of each type, i.e. I and II. Keratin heterodimers 
combine with each other to form tetramers. Eight tetramers consisting of two antiparallel 
coiled-coil dimers form the unit-length filaments (ULFs). Next, ULFs anneal into the filaments 
(Herrmann et al., 2009). Adapted from (http://www.interfil.org). 
 However, K8 and K18 may also be found in mesenchymal cells such as smooth 
muscle cells and fibroblastic reticulum cells of lymph nodes as well as various 
mesenchymal tumors, where they co-express with vimentin and desmin (Franke and 
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Moll, 1987; Huitfeldt and Brandtzaeg, 1985; Jahn and Franke, 1989). K19 is important 
for normal muscle function and its deficiency leads to myopathy (Stone et al., 2007).  
K7 and K19 are found in ductal epithelia, mesothelium and urothelium, whereas in the 
intestine K19 is also co-expressed with K8 which is found abundantly in intestinal 
epithelium. K20 has the most restricted expression in gastrointestinal epithelium, 
urothelium and neuroendocrine cells like Merkel cells in skin. K20 is absent from the 
stem cell compartment and appears to start expressing during terminal differentiation 
(Moll et al., 2008). K23 is expressed in colonic and pancreatic tumor cells undergoing 
differentiation by a mechanism encompassing histone hyper-acetylation (Omary et al., 
2009; Zhang et al., 2001).  
2.2.3. Keratin Regulation 
SEKs are regulated by two major mechanisms, i.e. posttranslational modifications 
(PTMs) and interaction with associated proteins. 
2.2.3.1. Keratins and PTMs 
Keratins are actively regulated by several PTMs, including phosphorylation, glycosylation, 
transglutamination, sumoylation, acetylation, ubiquitination and prenylation (Omary et 
al., 2004; Omary et al., 2006). These modifications mostly occur in non-conserved 
head and tail domains affecting tissue specific functions of SEKs in different organs, as 
evident from several studies utilizing in vitro and in vivo models (Omary et al., 2006; 
Toivola et al., 2004b). Like other IF proteins, PTMs are important for keratin filament 
assembly and disassembly (Hyder et al., 2008; Izawa and Inagaki, 2006; Omary et al., 
2006; Sihag et al., 2007).  
The most commonly found and significant PTM in SEKs is phosphorylation. IFs can 
be phosphorylated by kinases activated during stress. This designates, mainly 
keratins, to be a phosphate sponge protecting tissues such as liver tissue from 
potential injuries (Ku et al., 1996; Liao et al., 1996; Omary et al., 2006). There is an 
adequate knowledge available about IF regulation due to the recent advances in 
understanding phosphorylation. Phosphorylation plays important roles in regulating 
filament organization, solubility, and cell-protective functions. A number of kinases 
and phosphatases modulate phosphorylation to facilitate IF re-organization by 
targeting one or more Ser/Thr residues, specifically in the N-terminal and C-terminal  
domains (Omary et al., 1998). Like other IFs, keratin solubility is based on Ser/Thr 
phosphorylation which guarantees the structural dynamics of filament (Guo et al., 
2008; Moritz et al., 2010; Rikova et al., 2007). K8, K19 and vimentin are the known 
IF targets for tyrosine phosphorylation and K8 phosphorylation at a highly conserved 
residue in the rod domain (Tyr-267) leads to keratin insolubility (Snider and Omary, 
2014; Snider et al., 2013b).  
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The serine-specific phosphorylation for K8, K18 and K19 is widely studied (Strnad et 
al., 2012a; Toivola et al., 2002; Zhou et al., 1999). Keratin phosphorylation helps to 
guard tissues and cells such as hepatocytes from injury (Omary and Ku, 2006; Omary 
et al., 2006). Knock-in mice with phosphorylation site mutations in the head domain of 
K8 (Ser74) or K18 (Ser54) show increased apoptosis and liver damage (Ku et al., 
1998a; Ku et al., 1998b; Ku and Omary, 2006). Studies with transgenic mice 
expressing either K8 Gly62Cys or K8 Ser74Ala showed that the carriers of the human 
K8 variant (Gly62Cys) are predisposed to liver disease by inhibition of K8 in vivo 
phosphorylation by the stress-activated p38 kinase at the adjacent K8 Ser74 (Omary, 
2009). Similarly, K18 Ser-52 and 33 are two phosphorylation sites which are important 
during mitosis and many stress conditions (Ku et al., 1998a).   
Previous studies have shown that other PTMs, such as glycosylation, can affect 
phosphorylation by blocking the access of kinases to serine (S) for kinases (Omary  
et al., 1998; Snider and Omary, 2014). Dephosphorylation also regulates SEK 
phosphorylation state and serine/threonine (S/T) phosphatase inhibitors calyculin-A 
(Cl-A), microcystin-LR and okadaic acid (OA) cause hyper-phosphorylation and 
disassembly of keratin filaments (Eriksson et al., 1998; Toivola et al., 2002). The 
filament organization and solubility can be disturbed by attached phosphates (Omary et 
al., 1998; Zhou et al., 1999). Disassembly of mainly insoluble filaments redistributes 
them to the soluble pools (Omary et al., 1998) and many studies have revealed the 
correlation between the phosphorylation and functions of SEKs in different in vivo and 
in vitro  models (Omary et al., 2006).  
Increased acetylation of K23, K8 and K18 has been reported in pancreatic cancer cells 
and colonic epithelia in response to butyrate (short chain fatty acid) treatment (Zhang 
et al., 2001). The increased acetylation is thought to be a regulatory mechanism of 
keratin stabilization. Keratins with different levels of acetylation most likely are able to 
regulate the homeostasis of epithelial cells by their loss or presence in the colon or 
pancreas (Zhang et al., 2001) (Leech et al., 2008). A recent study shows that keratin 
filaments can also be regulated by a novel mechanism involving K8 acetylation via 
glucose and SIRT 2 (Snider et al., 2013a).  
The process by which IFs are modified by small ubiquitin-like modifier (SUMO) 
proteins in a covalent and reversible manner is termed sumoylation (Geiss-Friedlander 
and Melchior, 2007). Sumoylation of keratin IFs is markedly increased by 
phosphorylation but the exact mechanism is not known (Snider and Omary, 2014). 
Mutation of the highly conserved phosphotyrosine, Tyr-267, in the K8 rod domain and 
the paralogous residue on GFAP (Tyr-242) leads to defective filament formation 
(Snider et al., 2013b). The use of PTMs in diagnostics and therapeutics for human 
diseases is an important avenue for future studies (Snider and Omary, 2014).  
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2.2.3.2. Keratin binding proteins 
Regulation of SEKs is mediated by their interaction with different proteins. In contrast 
to MTs and MFs, relatively few keratin-associated proteins, i.e. hsp70 and some cell 
signaling proteins, including 14-3-3 proteins, desmoplakins, Raf-1 kinase, p38 and Jun 
kinases, PKC, and protein phosphatase-2A, are known (Liao et al., 1995; Omary and 
Ku, 2006; Yin and Green, 2004). It is well established in cell culture and in vivo 
studies that K18 binds to 14-3-3 protein during mitosis and that it is regulated by K18 
S33 phosphorylation. A mutation in the K18 S33 phosphorylation site results in 
collapsed keratin filaments, in a tissue- and context-dependent fashion (Omary et al., 
2006),(Ku et al., 1998a). The 14-3-3 protein serves as a molecular scaffold for different 
signaling molecules, e.g. Raf kinase (Yaffe et al., 1997). A few studies have revealed 
that K8 bound to 14-3-3 is a possible regulatory protein for Raf, which in turn might 
phosphorylate K18 (Ku et al., 2004). 
It has been shown earlier that keratins also play an important role in wound healing by 
a mechanism involving K17 phosphorylation and binding to 14-3-3, leading to 
activation of the mTOR signaling pathway (Kim et al., 2006; Omary and Ku, 2006). 
K8/K19 may bind to γ-tubulin complex protein (GCP6) that joins MTs with IFs. 
Previous studies using transgenic K8-/- mice and Caco-2 cell line have revealed that 
this process is upregulated by the cyclin-dependent kinase 1 (Cdk-1), which 
phosphorylates the GCP6 protein. The attached phosphate helps GCP6 o bind to 
K8/K19. This is evident by keratin involvement in MTs distribution within epithelia 
(Oriolo et al., 2007a).  
Keratins are connected with MFs through plastin 1 (Pls1) which is one of the major 
actin-bundling proteins in the microvilli and binds to K19. Pls1 knock out (-/-) mice 
have shorter villi and fragile microvilli brush border due to the absence of Pls1. These 
findings indicate that the mechanical strength of the intestinal epithelium is dependent 
on actin-Pls1-K19 interactions (Grimm-Gunter et al., 2009). Trichoplein is another 
keratin-binding protein which binds to K8/K18 and is also found concentrated in 
desmosomes. This protein is thought to be involved in the organization of the apical 
network of keratin filaments and desmosomes in simple epithelial cells (Nishizawa et 
al., 2005). The regulatory role of SEKs in small intestine and colon is evident by the 
presence of many keratin-associated proteins in these organs. 
2.2.4. Functions of SEKs 
Keratins play important roles in cellular integrity, cell signaling, protein targeting, 
apoptosis and in protection against stress (Ku and Omary, 2006; Pallari and Eriksson, 
2006; Pan et al., 2013; Toivola et al., 2010; Toivola et al., 2005).  
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2.2.4.1. Scaffolding and cytoprotective functions of SEK  
Like other IFs, keratins also play a chief role in scaffolding the epithelial cells and 
stabilizing the cellular architecture in protection against mechanical and non-
mechanical stresses (Coulombe and Omary, 2002; Marceau et al., 2001; Omary and 
Ku, 2006; Omary et al., 2002). The cytoprotective functions of K8 and K18 are well 
supported by transgenic animal models including over expression of K18 or by -/- mice 
for K8 and K18 involving epithelial cells of liver, skin, cornea and oral cavity. The 
liver phenotype of K8-/- and K18-/- mice is obvious as hepatocytes from these mice lack 
keratin filaments and are therefore more susceptible to liver injury (Baribault et al., 
1994; Caulin et al., 2000; Gilbert et al., 2001; Loranger et al., 1997; Magin, 1998; 
Magin et al., 1998; Marceau et al., 2001; Omary et al., 2002; Toivola et al., 1998; 
Zatloukal et al., 2000). The functions of SEK may vary depending on the tissues. For 
example, K8-/- hepatocytes and pancreatic acinar cells are devoid of all keratins, but 
K8-/- pancreata showed similar susceptibility to injury as K8+/+ mice (Toivola et al., 
2000b). In contrast to K8/18 expression in the liver and K8/19 expression in the colon, 
the mouse gall bladder expresses K8, K18 and K19 with low levels of K7. Previous 
studies showed that different keratin null mice show different compensatory keratin 
expression in the absence of type I or type II keratins. For instance increased K20 
expression is seen in K19-/- gallbladders in contrast to K18-/- gallbladders (Tao et al., 
2003). K8-/- gallbladder shows marked increase in K7 levels while the liver does not 
show such an increase. It is important to mention here that the gallbladder  has several 
keratins to start with (Tao et al., 2003) but the liver has only one type II (Omary et al., 
2002) and K7 loss in K7-/- mice is not compensated by other keratins (Sandilands et al., 
2014). 
Cells and tissues regularly face many intrinsic and extrinsic stressful conditions. These 
intrinsic conditions include genetic and endoplasmic reticulum stress, whereas extrinsic 
or environmental stresses include heat, toxin, radiation, mechanical and infection. 
These extrinsic stresses can be of osmotic, oxidative and metabolic nature such as 
hypoxia and autophagy (Fig. 5). The cells respond to stress situations by heat stress 
response and upregulation of proteins which protect them from being damaged 
(Toivola et al., 2010). Previous studies have shown that mRNA and protein levels of 
resident or transient keratins are upregulated under various types of stress (Toivola et 
al., 2010).  
Like other IFs, keratin filaments have a unique feature that enables them to be 
stretched 3 times longer than their original size before breaking (Gu and Coulombe, 
2007; Haines and Lane, 2012; Kim et al., 2010; Pekny and Lane, 2007). The 
identification of K5 and K14 mutations in the patients suffering from epidermolysis 
bullosa simplex (EBS) was proved as first connection between IFs and mechanical 
stress (Coulombe et al., 2009). Similarly, fragile liver phenotype was seen in K8-/-, 
K18-/- and K18 R90C mutant mice (Omary, 2009). As SEKs are expressed in an 
epithelial cell- and differentiation state-selective manner, their upregulation has been 
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shown, for example after griseofulvin-induced injury in mouse liver (Cadrin et al., 
2000), caerulein- and choline/methionine-deficient diet (CDD), ethionine-
supplemented diet (CDE), CDD-induced injuries in pancreas (Zhong and Omary, 
2004) and high-fat lithogenic diet (LD) induced gallbladder injury (Tao et al., 2003). 
Stress is also often accompanied by increased keratin phosphorylation and other post-
translational modifications (Omary et al., 2006; Toivola et al., 2005) and in patients 
with liver cirrhosis, keratin phosphorylation correlates with disease prognosis (Toivola 
et al., 2004b). In lungs, shear stress results in increased keratin solubility, degradation, 
aggregation and K8/18 phosphorylation (Flitney et al., 2009; Ridge et al., 2005; 
Sivaramakrishnan et al., 2008). K8/18 hyper-phosphorylation is detected in liver, lungs 
and skin under stress conditions like hepatotoxicity, heat and drugs (Liao et al., 1997). 
The upregulation of IFs has also been seen during tissue repair processes. The mRNA 
levels of K6, K16 and K17 are increased during skin injury (DePianto and Coulombe, 
2004; Omary and Ku, 2006). Upregulation of K19 and K20 has also been reported 
during recovery from pancreatitis. Nestin and Vimentin have also been upregulated 
during repair from damaged muscle (DePianto and Coulombe, 2004). It was recently 
shown that K8 plays an important role in β-cell intracellular organization and systemic 
blood glucose control in normal homeostasis and diabetes (Alam et al., 2013).  
2.2.4.2. Protein targeting functions of SEK 
Unlike actin and microtubules, the role of IFs in membrane transport could not be 
widely studied until the 21st century due to the absence of IF polarity and specific 
motors and due to the non-availability of pharmacological agents. However, recent 
studies have provided significant evidence for the role of IFs in membrane protein 
targeting and organelle positioning (Styers et al., 2005). IFs may overcome their 
limitations by binding with other cytoskeletal elements, i.e. actin and microtubules and 
their specific motor proteins to perform their protein targeting and transport functions 
(Chang and Goldman, 2004; Helfand et al., 2003; Helfand et al., 2004; Strelkov et al., 
2003). Previous studies have suggested that the golgi apparatus and autophagosome 
functions may regulate IFs. This is evidenced by the bundling of vimentin filaments in 
response to the overexpression of vimentin binding proteins and defective 
accumulation of phagosomes (Blankson et al., 1995; Gao and Sztul, 2001; Gao et al., 
2002; Holen et al., 1992).  
Many studies using K8-/- intestine and liver cells and K18 R90C-expressing cultured 
cells helped in revealing the non-mechanical roles of SEKs in crucial cellular processes 
like protein localization and targeting, protein synthesis and epithelial cell polarity 
(Oriolo et al., 2007b; Toivola et al., 2005). The K8-/- small intestine and colon show 
mistargeting of ion transporters resulting in diarrhea (Ameen et al., 2001; Toivola et 
al., 2004a). The K8-/- liver has increased basolateral distribution of the bile canaliculus 
Ecto-ATPase (Ameen et al., 2001), increased apical distribution of the Fas receptor 
(Gilbert et al., 2001), and reduced desmoplakin deposition at desmosomes (Loranger et 
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al., 2006). Similarly, K18 R90C expressing cells show redistribution of E-cadherin 
(Hanada et al., 2005).  
2.2.5. Human diseases linked with SEK IFs 
SEKs are involved in human diseases with altered epithelial morphology and 
physiology. The cytoprotective functions of SEK are well established by keratin 
mutations predisposing to skin and liver diseases in humans. Many studies using 
mouse models have also reported the multiple disease associations with keratin 
mutations (Coulombe and Omary, 2002; Omary et al., 2009), (Usachov et al., 2012). 
In contrast to epidermal keratins, which when mutated mostly have a dominant-
negative effect, the simple epithelia keratins appear to act as susceptibility factors. 
Most mutations are missense mutations in conserved amino acid sequences of the α-
helical domain in the keratin protein. These mutations can influence directly or 
indirectly by predisposing their carriers to disease in many tissues (Fig. 6) (Omary et 
al., 2004), http://www.interfil.org, (Owens et al., 2004).  
Previous studies clearly showed that the liver is the primary target of these mutations. 
Since 12 % of patients suffering from liver diseases have K8/K18 mutations(Omary et 
al., 2009). Keratin variants are found in approximately 4% of the white population and 
predispose to development and adverse outcome of multiple liver diseases like 
Hepatitis C (HCV) (Strnad et al., 2012a). The transgenic K8-/- and K18-/- mice have a 
fragile liver (Omary 2009) and are susceptible to apoptosis and liver injuries (Ku and 
Omary 2006) partly due to changes in phosphorylation of K8 at S74 which is 
responsible for cytoprotection of liver cells (Ku 2007). Formation of cell specific 
inclusion bodies, i.e. Mallory-Denk bodies (MDBs), are also a hallmark for chronic 
liver diseases such as alcoholic and nonalcoholic steatohepatitis (NASH) or copper 
storage diseases (Ku et al., 2007; Zatloukal et al., 2007) and may be found in 
hepatocellular carcinoma and apoptotic hepatocytes (French et al., 2013). MDBs are 
made up of K8/K18 that have been ubiquitinated, or bound by other proteins such as 
heat shock proteins, or p62. MDBs also play an important role in protection against 
apoptosis and are targets of autoantibodies. MDBs are also sometimes observed in 
additional diseases such as chronic hepatitis C (CHC) (Rakoski et al., 2011). However, 
the exact function of MDBs is still unknown (Ku et al., 2007; Zatloukal et al., 2007).  
Several human diseases have been linked to mutations in SEKs and epidermal 
keratins. For instance, mutations in K5/K14 leads to epidermis bullosa simplex 
(EBS), an inheritable skin blistering disorder in which the epidermis is detached from 
the connective tissue due to a tissue breakdown in the epidermis (Bolling et al., 
2011). K8 mutations have also been thought to predispose humans to pancreatitis but 
a clear correlation is still lacking (Omary et al., 2009). 
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There is no clear evidence for the relevance of SEK mutations to intestinal diseases. 
The involvement of K8 mutations in IBD is hypothetically based on the K8-/- mouse 
model. The ablation of K8 seems to develop colonic epithelial hyperproliferation and 
IBD, which was observed in some patients with K8 mutations, but this correlation 
needs further investigations (Omary et al., 2009). A recent study using the in vitro 
colonocyte model clearly showed that the K8 mutations (K8 G62C, K8 K464N) and 
the K18 mutation (K18 S230T) affect the barrier function in intestinal epithelium. 
Therefore, these mutations may be considered as susceptibility factors for IBD 
(Zupancic et al., 2014). 
IFs are broadly used in diagnostics and disease activity evaluation while serving as 
autoantigens and markers for tumors and tissues due to their tissue specificity and 
abundance in cells (Omary et al., 2009; Strnad et al., 2012a). For instance, many 
adenocarcinomas have been characterized by the high expression of K7, K8, K18, K19 
and K20 (Moll et al., 2008; Omary et al., 2009). Recent studies have shown that K14 
and K17 expression may be used as a biomarker for breast and gastric cancer 
progression respectively (Cheung et al., 2013; Ide et al., 2012). 
Epithelial and non-epithelial tumors can be differentiated on the basis of pan-keratin 
staining (Moll et al., 2008). Similarly, specific keratin expression patterns may help 
predict the origin of primary tumors along with the probability of tumor growth (Moll 
et al., 2008). K8 and K18 are highly expressed in hepatocellular carcinoma, whereas 
cholangiocarcinomas are associated with specific expression of K7, K8 and K18. 
Similarly, K20 is highly expressed in colorectal cancer (Chu and Weiss, 2002; Moll et 
al., 2008). The presence of SEKs or SEK fragments in serum can be used as markers 
for apoptosis because of caspase mediated cleavage of K8/18 during apoptosis (Linder, 
2007; Moll et al., 2008; Omary et al., 2009). Tissue polypeptide antigen (TPA) which 
is a mixture of K8, K18, and K19, tissue polypeptide-specific antigen (TPS, derived 
from K18), cytokeratin fragment 21-1 (CYFRA 21-1; derived from K19) and a 
caspase-generated fragment of K18, can be used as a potential serum marker in the 
diagnostics of epithelial cell associated carcinomas such as colorectal, breast, lung and 
bladder cancer. These markers can also be used to monitor treatment responses and 
tumor prognosis (Duffy, 2006; Nisman et al., 1998). Auto-antibodies are not normally 
present in serum but are produced as a result of cell death leading to exposure to the 
immune system. Necrosis and apoptosis-generated keratin serum fragments can also be 
used as noninvasive markers of multiple liver diseases, particularly NASH (Strnad et 
al., 2012a). Like SEK serum markers, SEK specific autoantibodies can be used for 
evaluating the disease prognosis and treatment response. Many studies have shown the 
development of auto-antibodies specific for SEKs during autoimmune and malignant 
liver diseases. SEK targeted auto-antibodies like K8/K18 antibodies have been 
detected in acute liver failure (Bernal et al., 2007; Le Naour et al., 2002; Li et al., 
2008). It has been previously found that patients with autoimmune hepatitis (AIH) 
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exhibit high titers of antibodies specific for K8, K18 and K19 which are decreased 
after corticosteroid treatment (Bernal et al., 2007). 
2.2.6. The role of SEKs in the small intestine and colon 
Simple intestinal epithelia express K7, K8 (type II) and K18, K19, K20 (type I) (Fig. 1, 
Fig. 4). A novel keratin, K23, is expressed insignificantly within normal colon 
epithelial cells, but strongly in the phosphorylated form in colorectal adenocarcinomas 
and has a potential role as a tumor suppressor in colorectal cancers (Birkenkamp-
Demtroder et al., 2007). SEKs in the intestine are responsible for protecting 
colonocytes from stresses by maintaining cellular integrity and stability. They also 
provide liver cells with protection against apoptosis; however, colonocytes show 
resistance to apoptosis in the absence of SEKs (Gilbert et al., 2001; Habtezion et al., 
2011; Habtezion et al., 2005; Herrmann et al., 2009; Marceau et al., 2001). The role of 
keratins in the intestine is ambiguous. The -/- mouse models have helped tremendously 
in understanding keratin functions in vivo and indicate the frequency of functional 
redundancy of SEK. The first breakthrough came in 1993, when Helen Baribault 
successfully created the K8-/- mouse. The deletion of the K8 gene possesses a strong 
effect on embryogenesis and gut functional integrity depending on the genetic 
background of the mouse. Fifty percent of the K8-/- mice with FVB/N background are 
embryonically lethal and develop ano-rectal prolapse. The female K8-/- mice are sterile 
(Baribault et al., 1994; Baribault et al., 1993). These K8-/- mice develop a Th2-type UC 
similar to humans (Habtezion et al., 2005), with epithelial hyperproliferation (Baribault 
et al., 1994; Toivola et al., 2004a). The K8-/-mice also display a dramatic alteration in 
ion transport, leading to chloride secretion (rather than uptake) caused by a distinct 
epithelial ion transporter mistargeting, resulting in diarrhea (Toivola et al., 2004a). 
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Figure 4. SEK distribution in small intestine and colon. K8 is abundantly found in the colon in 
contrast to the scarce amount of K7 which is found in the crypt base and goblet cells. K18 and 
K19 are distributed uniformly throughout the villus-crypt axis in the colon. K20 is found in the 
upper parts of colonic crypts. On the other hand, the small intestine contains K8 and K19 as 
abundant and uniformly distributed keratins, but K7 and K18 are preferentially located in the 
crypt base with suprabasally located goblet cells. K20 is also found suprbasally in the villus. 
Modified from (Zhou et al., 2003). 
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Figure 5. Different forms of stress modulate IFs. Cells experience different kinds of stresses 
and respond according to form and duration of stress such as formation of inclusion bodies, up-
regulating or reorganizing the IFs.  Modified from (Toivola et al., 2010). 
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Figure 6. SEK mutations predispose carriers to different diseases. Studies utilizing animal 
models and human patients show that mutations in keratins lead to the phenotypes in liver, 
pancreas, and intestine. +, positive phenotype; -, absent phenotype; +/-, borderline phenotype; ?, 
untested and therefore unknown. Adapted from (Omary et al., 2009). 
The intestinal phenotype of K8-/- mimics the UC phenotype of IBS in humans. The K8-
null inflammation and ion transporter mistargeting can be ameliorated by using 
antibiotics. This suggests the involvement of microflora in K8-/- colitis (Habtezion et 
al., 2011; Habtezion et al., 2005). SEK’s hallmark of cell and tissue specific expression 
is highlighted by K8-/- mice showing susceptibility to apoptosis in the liver but, on the 
other hand, resistance to apoptotic cell death in the intestine (Habtezion et al., 2011). 
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Interestingly, the K8+/- mice, which express less K8 levels as compared to K8+/+ mice, 
display a similar but milder ion transport-defect with reduced short circuit current, 
decreased Na+ and Cl- absorption, although no major inflammation is observed under 
baseline conditions (Toivola et al., 2004a). On the basis of these findings we 
hypothesized that the concentration of colonocyte keratins, or an intact keratin 
network, is indispensable to protect colonocytes from stress (colitis). K18-/-/K19-/- 
(double -/-) mice show early embryonic lethality (Hesse et al., 2000). K7-/- and K19-/- 
mice do not have intestinal phenotype (Sandilands et al., 2014; Tamai et al., 2000). In 
vitro studies also revealed that K8 ablation leads to development of shorter microvilli 
in Caco-2 cells silenced for K8 (Salas et al., 1997). K8 plays an important role in the 
early scaffold organization in the apical domain of polarized epithelial cells (Wald et 
al., 2005). Recently, it has been shown that K8 plays a role in colonocyte energy 
metabolism and homeostasis. Mitochondria of K8-/- colonocytes have decreased levels 
of ketogenic enzyme, HMGCS2, leading to aberrant ketogenesis in K8-/- colon. The 
K8-/- colon also shows downregulation of PPARα and the SCFA (butyrate) transporter 
MCT1 (Helenius et al., 2015). 
2.3. Epithelial ion transport 
The main function of the adult colon is to absorb Na+, Cl-, K+, short chain fatty acids 
(SCFAs) and fluid, including water, as well as to secrete HCO3- and mucus (Field, 
2003). The osmotic gradient created by salt transport using ion transporters and 
channels is the driving force for passive water movement in/out of the lumen.  
2.3.1. Ion transporters 
The electroneutral sodium chloride (NaCl) absorption is the key process which enables 
Na+, Cl- and fluid absorption in the intestine. NaCl absorption in the gastrointestinal 
tract involves coupling of Na+/H+ and Cl-/ HCO3- exchangers (Kato and Romero, 2011) 
(Fig.7). 
2.3.2. Sodium transporters 
Active Na absorption takes place either through electrogenic transport (e.g. the 
epithelial Na+ channel ENaC) or through electroneutral NaCl absorption, generally a 
result of coupled Na+/H+ and Cl-/HCO3- exchangers. The luminal-membrane sodium 
hydrogen exchange is mediated through SLC9A2 [solute carrier family 9 member A2; 
also called NHE2 (sodium hydrogen exchanger 2)] and SLC9A3 (also called NHE3) of 
the SLC9 gene family.  
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2.3.2.1. ENaC 
The epithelial Na+ channel (ENaC) is responsible for transporting Na+ across epithelia 
of many organs including the distal colon. ENaC comprises three subunits, α, β, and 
γ, each subunit ranges between 85 to 95 kD in size. PTMs are important in the 
regulation of ENaC activity and expression (Canessa et al., 1993; Canessa et al., 1994). 
Disturbances in Na+ and Cl- absorption in the colon are associated with diarrheal 
disorders like cystic fibrosis (CF) and UC and a decreased expression of ENaC 
subunits is seen in human biopsy samples from patients with colitis (Greig et al., 
2004; Kunzelmann and Mall, 2002). 
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Figure 7. Candidate ion transporters for electroneutral NaCl absorption. Based on 
(Kunzelmann and Mall, 2002; Malakooti et al., 2011).     
2.3.2.2. NHE 
Sodium hydrogen exchangers (NHE) belong to the SLC9 gene family and are the main 
Na+ transporters in the ileum and proximal colon. Out of 9 members of this gene 
family, NHE1, NHE2, NHE3 and NHE8 are expressed in mammalian intestine (Dudeja 
et al., 1996; Xu et al., 2005). NHE1 is localized in the basolateral membrane of  IECs 
and performs housekeeping functions (Sardet et al., 1989). NHE2 and NHE3 are 
situated in the apical membrane and serve in intestinal Na+ absorption (Wormmeester 
et al., 1998). NHE2 and NHE3 are predominantly expressed in the colon and ileum, 
respectively (Bachmann et al., 2004; Dudeja et al., 1996). Although NHE3-/- mice have 
an intestinal phenotype with mild diarrhea, low blood pressure and mild metabolic 
acidosis, NHE2-/- mice seem to have normal intestinal Na+ absorption (Gawenis et al., 
2002). NHE8 is differentially expressed along the human gastrointestinal tract and 
important in early life (Bobulescu and Moe, 2009), but its functional role in Na+ 
absorption in the adult intestine is not clear.  Several studies have correlated the 
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impaired Na+ absorption with NHE3 down-regulation during diarrheal disorders like 
IBD (Greig and Sandle, 2000).  
Butyrate has been shown to enhance Na+ absorption by increasing NHE2 and NHE3 
levels in rat distal colon (Binder and Mehta, 1989; Krishnan et al., 2003). Diarrhea is a 
characteristic feature of IBD and has been shown to be contributed by inflammation 
and pro-inflammatory cytokines like IFNγ, TNFα, and IL-1β in the intestine. Colonic 
inflammation and treatment of mice with TNFα and IFNγ have been shown to result in 
decreased expression and activity of NHE3 (Amin et al., 2006; Barmeyer et al., 2004; 
Rohlff et al., 1997).    
Reduced NHE3 function has been observed in UC, but NHE3 mRNA and protein 
levels were not altered indicating the importance of its transcriptional regulation 
(Sullivan et al., 2009; Yeruva et al., 2009). TNBS and LPS treatment results in reduced 
NHE8 mRNA and protein levels in rats (Xu et al., 2009). Glucocorticoids, epidermal 
growth factor (EGF) and phorbol 12-myristate 13-acetate (PMA) have also been found 
to increase NHE3 activity in the mammalian intestine (Malakooti et al., 2005; Yun et 
al., 1993).  
2.3.3. Chloride transporters   
The luminal membrane Cl−/HCO3− exchange is mediated by SLC26A3 [also called 
DRA (down-regulated in adenoma)] and SLC26A6 [also called PAT-1 (putative anion 
transporter 1)] of the SLC26 gene family (Kato and Romero, 2011; Mount and 
Romero, 2004). DRA and PAT-1 are expressed ontogenically and variably along the 
length of the intestine (Farkas et al., 2010; Walker et al., 2008) and the crypt-villus 
axis. The specific expression of these transporters depends on transcriptional regulation 
(Farkas et al., 2010; Walker et al., 2009). The basolateral chloride transport is mediated 
by the anion exchanger AE1/2.  
2.3.3.1. AE1/2 
The AE1/2 is expressed basolaterally in erythrocytes, heart, distal colon and kidney 
epithelial cells (Alper et al., 1997; Holappa et al., 2001). Distal renal tubular acidosis is 
caused by mutations in the gene encoding AE1. The AE1/2-/- mice suffer from 
achlorhydria and osteoporosis leading to their death. A hypomorphic AE2-/- mice with 
partial loss of AE2 gene are viable but develop defective spermatogenesis leading to 
male infertility and a syndrome resembling primary biliary cirrhosis (Alper, 2009).  
2.3.3.2. PAT-1 
The PAT-1 (SLC26A6) gene is located on chromosome 3p21.3 and consists of 21 exons 
and 20 introns. The PAT-1 gene encodes an integral membrane protein of 738 amino 
acid with a predicted topology of 11 transmembrane helices and an intracellular -NH2 
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and -COOH terminus (Lohi et al., 2003; Waldegger et al., 2001). The apical Cl−/HCO3− 
exchange is controlled by PAT-1 in the small intestine, as it is predominantly expressed 
in the small intestine and in very low levels in the colonic crypts (Wang et al., 2002). 
PAT-1 expression was found to be decreased in Caco-2 cells by the pro-inflammatory 
cytokine IFNγ albeit via a distinct cis element/transcription factor (Saksena et al., 2008). 
PAT-1 plays an important role in Cl− absorption without being coupled to water 
movement as evidenced by decreased Cl-/HCO3- exchange activity in PAT-1-/- mice 
without any diarrheal phenotype (Wang et al., 2005).  
2.3.3.3. DRA 
SLC26A3 belongs to a solute carrier family and is normally expressed in the colon but 
not found in colonic adenomas/adenocarcinomas. The SLC26A3 gene encodes a 
glycoprotein of 764 amino acids (Byeon et al., 1996). DRA has been identified as the 
major Cl−/HCO3− exchanger involved in electroneutral NaCl absorption in the intestine 
(Musch et al., 2009; Walker et al., 2008). Mutations in human DRA (hDRA) gene have 
been associated with the development of congenital chloride diarrhea (CLD). CLD is 
an autosomal recessive disorder and results in watery stool with high chloride 
concentration and metabolic alkalosis (de la Chapelle, 1993; Hoglund et al., 1996; 
Makela et al., 2002). Unlike PAT-1, DRA activity is coupled to water movement. 
DRA-/- mice exhibit a diarrheal phenotype, including chloride losing diarrhea, colonic 
hyperplasia and upregulation of ion transporters such as NHE3 and H,K-ATPase in the 
colon. This phenotype resembles CLD in humans (Schweinfest et al., 2006).  Unlike 
PAT-1, DRA is mostly expressed in the colon and to a lesser amount in the small 
intestine and is localized to apical membranes of IECs (Farkas et al., 2010; Kato and 
Romero, 2011). DRA is expressed ontogenically in the surface epithelium and upper 
colonic crypts (Yang et al., 1998). DRA is upregulated in the colon of NHE3-/- mice, 
indicating its role in chloride absorption (Melvin et al., 1999). Some of the previous 
studies have also shown downregulation of DRA under Citrobacter rodentium 
driven intestinal inflammation (Borenshtein et al., 2008a; Farkas et al., 2010; 
Saksena et al., 2010; Yang et al., 1998), while an increased DRA expression 
has been observed in response to anti-inflammatory/pro-absorptive agents such as 
probiotics, i.e. lactobacillus acidophilus and butyrate (Alrefai et al., 2007; Raheja et al., 
2010).  
Long-term regulation of gene expression is associated with physiological or 
pathophysiological changes in the intestine such as in response to luminal SCFA 
butyrate, or IBD (Malakooti 2011). Reduced DRA expression has been shown in 
patients with UC, as well as in the IL-10-/-  mouse (Kuhn et al. 1993) and the HLA-
B27/2m transgenic rat, which are two known in vivo models of colitis (Farkas et al., 
2010; Yang et al., 1998). Cell culture studies showed decreased DRA expression in 
response to pro-inflammatory cytokines IL1β and IFNγ (Saksena et al., 2008; Saksena 
et al., 2010; Yang et al., 1998). The mechanism of DRA inhibition by IFNγ involves 
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JAK1 and JAK2 and STAT1. JAK1 and JAK2 are activated by the binding of IFNγ to 
its surface receptor, which results in phosphorylation and activation of the latent 
cytosolic STAT1. STAT1 is further dimerized and translocates to the nucleus (Decker 
et al., 1991; Levy, 1998; Liu et al., 1998) where it binds to the GAS element of the 
DRA promoter. This, in turn, leads to a decrease in the DRA mRNA, protein 
expression and function (Fig. 8) (Saksena 2010).  
Enteropathogenic E. coli (EPEC) infection decreases DRA surface expression via 
disruption of microtubules in the mouse colon (Gill et al., 2007). A recent study 
showed that DRA-/- mice are susceptible to DSS colitis. The study showed that the 
absence of DRA caused a reduced colonic HCO3- secretory rate, a loss of colonic fluid 
absorption, a lack of a firmly adherent mucus layer and a severely reduced colonic 
mucosal resistance to DSS damage (Xiao et al., 2014).   
 
Figure 8. Proposed model for inhibition of DRA by IFNγ. Binding of IFNγ to its 
receptor activates JAK-1/2. Activated JAK 1and 2 then phosphorylate and activate cytoplasmic 
STAT1, which dimerizes and is translocated to the nucleus. In the nucleus, phosphorylated 
STAT1 binds to the GAS element of the DRA promoter which in turn leads to a decrease in 
DRA mRNA, protein expression and function. Adapted from (Saksena et al., 2010).  
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2.3.3.4. CFTR 
Cystic fibrosis transmembrane conductance regulator (CFTR) is a cAMP-regulated Cl- 
channel. CFTR is expressed in the apical membrane of epithelia and mediates salt and 
liquid movement (Sheppard and Welsh, 1999). Dysfunction of CFTR causes a genetic 
disease called cystic fibrosis (CF), whereas a defect in the activity of this chloride 
channel is seen in diarrhea and in polycystic kidney and lung diseases (Linsdell, 2014; 
Molina et al., 2015). Mutations in the CFTR gene result in both impaired Cl- secretion 
and enhanced Na+ absorption in the colon among CF patients (Kunzelmann and Mall, 
2002).  
2.3.4. Keratins in intestinal ion transport 
Lack of K8 leads to the development of Th2-colitis and abnormal intestinal ion 
transport in transgenic mice. In ussing chamber experiments K8-/- mice show a 
dramatic decrease in short circuit current and net sodium absorption in the distal colon 
but have normal tight junction permeability and paracellular transport when compared 
to K8+/+ mice (Toivola et al., 2004a). Interestingly, the K8+/- distal colon that expresses 
approximately 50% less keratins compared to K8+/+, has an intermediate ion transport, 
short circuit current and proliferation phenotype, but no inflammation (Toivola et al., 
2004a). The K8-/- small intestine appears normal compared to the K8-/- colon, but 
mistargeting of epithelial ion transporters has been reported (Ameen et al., 2001). As 
mistargeting of membrane proteins in the intestine of K8 null mice is relatively 
widespread (Ameen et al., 2001), the direct or indirect consequences result in 
modulation of Na+ and Cl- transport and diarrhea, which precede hyperproliferation 
and inflammation (Toivola et al., 2004a). K19 is expressed in the apical submembrane 
cytoskeleton in different epithelia including non-brush border cells and it plays an 
important role in the organization of the apical pole in epithelial cells (Salas et al., 
1997). Studies using K8-/- mice have revealed that K19 is required for the apical 
localization of γ-tubulin complex protein (GCP) 6 and γ-tubulin (Salas, 1999). K18 has 
been shown to interact with the C-terminal hydrophobic patch of CFTR leading to high 
expression of the latter. In vivo studies utilizing K18-/- mice revealed low surface 
expression of CFTR in duodenal and gallbladder epithelia. Therefore, K18 plays an 
important role in the regulation of CFTR and K8/K18 may be modifier genes in cystic 
fibrosis (Duan et al., 2012).  
2.4. Inflammatory Bowel Disease (IBD) 
Inflammatory bowel disease (IBD) is a group of chronic inflammatory conditions of 
the colon and small intestine caused by multi-factorial conditions in a genetically 
predisposed host  (Baumgart and Carding, 2007; Kaser et al., 2010; Rocchi et al., 2012; 
Xavier and Podolsky, 2007). This may be well supported by the hygiene hypothesis, 
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suggesting that the lack of exposure to infectious agents due to high-quality living 
standards and medical conditions, increases the risk of inflammatory and autoimmune 
disorders like IBD (Feillet and Bach, 2004; Garn and Renz, 2007). The most prevalent 
IBDs include UC and Crohn’s disease (CD). 
The annual incidence of UC in Europe ranges from 0.6-24.3 per 100,000 persons per 
year in comparison to Asia and Middle East with an incidence of 0.1-6.3 per 100,000 
persons per year (Logan, 1998).  The annual incidence of CD in Europe ranges from 
0.3-12.7 per 100,000 persons per year in contrast to lower incidence ranging from 
0.04-5.0 per 1000 persons per year in Asia and the Middle East (Molodecky et al., 
2011). The highest incidence of IBD has been reported in Northern Europe and North 
America (Lakatos, 2006). In Finland, an increasing incidence of IBD has been 
reported. In 1993, IBD prevalence was recorded as 216 per 100,000 inhabitants and in 
2013 the number of patients reached 595 per 100,000 inhabitants. The prevalence of 
IBD and especially UC was much more increased in northern Finland when compared 
to the southern part of the country (Jussila et al., 2012). IBD causes a considerable 
financial burden to the health care system in the European society. Around 2.5-3 
million Europeans are affected by IBD and 4.6-5.6 billion Euros/year are spent for 
disease management (Burisch et al., 2013).  
Mouse models of colitis provide vital tools facilitating the study of the molecular and 
pathophysiological mechanisms which are responsible for IBD initiation and 
progression (Mizoguchi and Mizoguchi, 2010; Wirtz and Neurath, 2007; Xavier and 
Podolsky, 2007). Genetic and chemical colitis mouse models provide the means for 
examining early and late inflammatory processes as well as for evaluation of new 
therapies still needed in the field (Hoffmann et al., 2002; Mizoguchi, 2012; Mizoguchi 
and Mizoguchi, 2010).  To date, numerous animal models have been developed to 
study IBD. These models include spontaneous colitis models, inducible colitis models, 
genetically modified models, and adoptive transfer models. Chemically induced 
murine models of colitis are widely used because they are simple, easy to induce and 
have quick onset and duration and the severity of inflammation is controllable. These 
models include DSS and trinitrobenzene sulfonic acid (TNBS) induced colitis which 
are commonly used animal models of mucosal inflammation in numerous studies 
focusing on IBD (Neurath et al., 2000; Wirtz et al., 2007; Wirtz and Neurath, 2007). In 
addition, several -/- and transgenic mice, such as the NOD22939insC mutant, NOD2-/-, IL-
12p35-/- and IL-10-/-, spontaneously develop intestinal inflammation (Wirtz and 
Neurath, 2007).  
Citrobacter rodentium serves as a bacterial model to study mucosal immunology, 
including the deregulation of intestinal inflammatory responses during bacteria-
induced colitis (Borenshtein et al., 2008b; Collins et al., 2014). Previous studies have 
successfully demonstrated that TLR4 and MyD88-/- mice have less pathology in 
response to DSS colitis, although bacterial translocation to mesenteric lymph nodes 
was more commonly detected (Fukata et al., 2005). Studies have shown that alterations 
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in TLR4 and TLR5 function has an effect on intestinal homeostasis and may lead to the 
development of metabolic syndrome (TLR5) (Rhee et al., 2005; Vijay-Kumar et al., 
2010). 
2.4.1. IBD diagnostics 
Conventional means to assess the severity of murine colitis longitudinally in vivo are 
either indirect, (such as body weight loss, stool hydration fecal blood content and 
disease activity index), or labor intensive (such as post mortem histopathology 
analysis) (Mizoguchi, 2012; Mizoguchi and Mizoguchi, 2010; Talapka et al., 2014; 
Wirtz et al., 2007; Wirtz and Neurath, 2000). In vivo imaging has revolutionized the 
research by providing non-invasive tools and recent developments in preclinical 
imaging modalities have improved the analysis of longitudinal studies of disease 
models (Beckmann et al., 2007).  
Studies in the recent past have shown that a few techniques have been developed 
for imaging the human or murine gastrointestinal tract, but these techniques have 
some technical limitations such as excessive motion artifacts due to peristalsis, 
cardiovascular pulsation and respiration (Jelicks, 2010). Current in vivo modalities 
include high-frequency micro-ultrasound, magnetic resonance imaging (MRI), computed 
topography (CT), optical imaging such as fluorescence and bioluminescence, 
positron emission tomography (PET) and single photon emission computed 
tomography (SPECT) (Willmann et al., 2008). MRI, CT and ultrasound are used for 
anatomical imaging, whereas optical imaging and PET are preferred for molecular 
levels studies. The use of radiations in CT, the high cost of MRI, the low sensitivity 
of ultrasound or invasive specific endoscopic techniques are the limitations in the 
cost effective and accurate diagnostics of IBD (Becker et al., 2005; Mitsunaga et al., 
2012; Moussata et al., 2010). There is a need to invent simple, non-invasive, cost 
effective and radiation-free imaging techniques both for human colitis diagnosis and 
murine model analysis (Fredin et al., 2008; Melgar et al., 2007; Strobel et al., 2011).      
2.4.2. Reactive oxygen and nitrogen species (RONS) in IBD   
Reactive oxygen species (ROS) are a heterogeneous group of oxygen radicals and 
other strongly oxidizing molecules and have similar characteristics as reactive nitrogen 
species (RNS). Reactive oxygen and nitrogen species (RONS) are well known for their 
roles in modulation of gene expression, cellular function, cellular damage and 
signaling. However, during the last decade there has been an increasing interest in 
revealing the mechanisms by which RONS act as signals or mediators of changes in 
cell function, proliferation and differentiation (Jackson et al., 2002; Sen and Packer, 
1996; Zhu et al., 2012). RONS are produced from both extracellular and intracellular 
sources. The extracellular RONS play a pivotal role in initiating cellular signaling by 
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activating growth factor and cytokine receptors without receptor ligands or via 
generation of lipid peroxides within cell membranes (Coffer et al., 1995; Hayes and 
Lockwood, 1987; Suzuki et al., 1997). On the other hand, intracellular production of 
RONS is governed by a number of stimuli like tumor necrosis factor-α (TNF-α) or 
other RONS via induction of NADPH oxidase (Suzuki et al., 1997). Interaction of 
platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) with their 
receptors causes a transient increase in hydrogen peroxide (Garcia-Ruiz et al., 1997; Lo 
and Cruz, 1995). However, excessive production of RONS may have deleterious 
effects such as damage to macromolecules and interruption of cellular signaling. 
Increased levels of RONS are a hallmark of inflammation and have also been found 
elevated in human and murine colitis (Kaser et al., 2010; Keshavarzian et al., 1992a; 
Keshavarzian et al., 1992b; Simmonds et al., 1992). RONS play an important role in 
immune response during inflammation but may also become deleterious by 
propagating an inappropriate inflammatory response in diseases like rheumatoid 
arthritis (Winrow et al., 1993). Increased levels of nitric oxide (NO) were found in the 
serum, colonic tissues and  cultured mucosal explant from IBD patients (Ljung et al., 
2002; Lundberg et al., 1994; Oudkerk Pool et al., 1995). RONS are commonly detected 
indirectly in colitis using microscopic or colorimetric assays for myeloperoxidase 
(MPO), which is an enzyme producing RONS in neutrophils that are present at the site 
of inflammation (Araki et al., 2006; Sedghi et al., 1993).  
2.4.3. Measurement of RONS and in vivo imaging of murine colitis   
There are many methods available, including biomarkers and probes, for the detection 
of RONS (Halliwell and Whiteman, 2004). A vast majority of these methods involve 
detection of antioxidant levels and oxidation metabolites in tissue and blood samples 
(Halliwell and Whiteman, 2004). In comparison to these indirect methods, genetically 
encoded fluorescent RONS indicators or injected, mostly luminescent RONS sensitive 
probes, such as luminol, lucigenin, and dihydroethidium (DHE), provide real time 
measurement of RONS (Lucas and Solano, 1992; Videla et al., 1993).   
Due to the short life span of RONS the conventional imaging methods are not 
effective enough. The use of different in vivo imaging techniques enables us to 
visualize the location of RONS production. These techniques use either genetically 
encoded fluorescent or chemiluminescent RONS sensitive probes. In vivo imaging 
may provide early and direct detection of RONS. The RONS levels in biopsies and 
cells have been detected by using luminol-enhanced chemiluminescence (Keshavarzian 
et al., 1992a; Keshavarzian et al., 1992b; Simmonds et al., 1992). 8-amio-5-chloro-7-
phenylpyrido[3,4-d] pyridazine-1,4-(2H, 3H) dione (L-012) is a luminol analog and 
chemiluminescent probe with high sensitivity for RONS and has been used in detection 
of RONS in cell culture (Daiber et al., 2004; Imada et al., 1999; Nishinaka et al., 
1993). The L-012 probe distributes widely in the mouse body and produces 
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chemiluminescence in a spatial and temporal manner corresponding to inflammation. 
This compound, thus, provides a simple and cost effective method to study regulation 
of RONS (Kielland et al., 2009). The same probe has also been used for in vivo 
imaging of lipopolysaccharide (LPS)-induced inflammation in animal models of 
arthritis (Kelkka et al., 2012a; Kielland et al., 2009). However, this probe has not yet 
been used for in vivo imaging of colitis. The short half-life of this probe makes its use 
limited and challenging. 
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3. AIMS OF THE STUDY  
The main aim of this study is to unravel the roles of keratins in intestinal homeostasis.  
Specific aims are as follows: 
A. To describe the baseline colonic phenotype of K8+/- mice as a possible model to 
address the roles of keratins in the intestine. 
B. To test if K8+/- mice have an increased susceptibility to experimental colitis. 
C. To understand how keratins may regulate ion transport or protein targeting in 
intestinal epithelia. 
D. To evaluate the possible use of L-012 for imaging colitis in vivo. 
E. To evaluate the difference of gene expression between K8+/+ and K8+/- mice to 
fully elucidate the function of K8.  
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4. MATERIALS AND METHODS 
The details of the methods used during the PhD studies are thoroughly described in the 
separate publications/manuscript (I-III). The following section describes briefly the 
methods used and those techniques not included in I-III. 
4.1. Mice (I, II, III) 
The K8-/-, K8+/- and K8+/+ mice in the FVB/n background were generated by 
interbreeding of K8+/- mice and genotyped as previously described (Baribault et al., 
1994; Toivola et al., 2004a). Pre-diabetic 4-5 week old female NOD mice (Alam et al., 
2010) and BALB/c control mice were bred and maintained in Turku University Central 
Animal Laboratory under specific pathogen free conditions. All animal experiments 
were approved by the Animal Experimental Board in Finland and conformed to the 
legal acts, regulations and requirements set by the European Union concerning 
protection of animals used for research. 
4.2. Microarray 
The colonic epithelial cells were isolated by scraping the whole colonic epithelium by 
the following method: The colon was excised and placed on an ice-cold glass surface. 
The colon was cut open longitudinally and rinsed with ice-cold phosphate-buffered 
saline. The colonic epithelium was collected by scraping with a glass slide . Total 
RNAs were isolated with NucleoSpin® RNA II kit (Macherey-Nagel, Germany). 
RNAs were reverse transcripted, labeled and hybridized to Illumina Sentrix Bead 
Arrays (Illumina, San Diego, CA) where the Illumina Mouse WG-6 v.2.0 Expression 
BeadChip was used (>45 000 transcript-specific probe sequences/array). RNA quality 
was controlled prior the amplification and labeling. The microarray assay was 
conducted by The Finnish Microarray and Sequencing Centre at Turku Centre for 
Biotechnology. After GO, KEGG and REACTOME annotations and analysis, genes 
with more than 1.5 fold change in the expression level were selected for further 
analysis. 
4.3. Real time PCR (I, II) 
Taqman RT-PCR (I): Total colon RNA was isolated from colon epithelial scrapings 
obtained by scratching the mucosa with a microscope slide. RNA was isolated using an 
RNeasy mini kit (Qiagen, Netherlands). Contaminating DNA was removed with 
DNase I enzymes (Promega, WI, USA) and the RNA quality was analyzed in a 1 % 
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agarose gel. 1 μg of each RNA sample was synthesized by reverse transcription to 
cDNA using a transcription kit (Promega, WI, USA). Target genes were amplified 
using specific primers (Supplemental Table 1, I) and KAPA probe Fast ABI Prism 
qPCR mix (Kapa Biosystems, MA, USA). qPCR was performed with Step One Plus 
Real-Time PCR system (Applied Biosystems, CA, USA). Gene expression levels were 
normalized to the housekeeping gene β-actin. Each cDNA was tested in a triplicate and 
the amplification was analyzed using a 1 % agarose gel. 
SYBER Green (II): Total RNA was extracted from epithelial scrapings of ileum, 
proximal and distal colon with a microscope slide. RNeasy Mini Kit (Qiagen; 
Netherlands) was used to isolate RNA according to the manufacturer’s instructions. 
Equal amount of RNA from K8+/+, K8+/- and K8-/- was reverse transcribed and 
amplified in one step reaction using Brilliant SYBR Green qRT-PCR Master Mix Kit 
(Agilent Tech., Santa Clara, CA). Gene expression levels were normalized to GAPDH 
(Kumar et al., 2014). 
4.4. Tissue lysates and western blotting (I, II) 
For western blotting, total lysates of colonic tissues were prepared by homogenization 
in a sample buffer containing 0.187M Tris-HCl pH 6.8, 3% sodium dodecyl sulphate 
(SDS) and 5m Methylene diamine tetra acetic acid (EDTA). Protein concentrations 
were measured using a Pierce BCA protein assay kit (Thermo Scientific, Waltham, 
MA, USA) and an equal amounts of protein were loaded and separated by SDS 
polyacrylamide gel electrophoresis, transferred to a polyvinylidene fluoride membrane 
and immunoblotted with indicated antibodies. Proteins were visualized using Western 
Lightning Chemiluminescence (Perkin-Elmer, Waltham, MA, USA). Protein signals 
were quantified from scanned films using ImageJ (National Institutes of Health, USA) 
by normalizing to Hsc70 (I). The western blot for II in collaboration with Prof. Dudeja 
at University of Chicago was performed using the following  method: Tissue lysates 
were prepared from colonic scrapings and total protein was extracted using RIPA lysis 
buffer (Cell Signaling, Danvers, MA) supplemented with protease inhibitor cocktail 
(Roche, Indianapolis, IN). A bullet blender was used to homogenize mucosa followed 
by sonication (three pulses for 20 s each). Cell debris was removed by centrifuging the 
lysates at 13000 rpm for 7 min at 4C. The Bradford method was used to determine the 
protein concentration in the samples. Equal amounts (75 µg/sample) of tissue lysates 
were solubilized in SDS-gel loading buffer and boiled for 5 min. Lysates were run on a 
7.5% SDS-polyacrylamide gel and transblotted to nitrocellulose membrane after 
electrophoretic separation. After one hour of incubation in blocking buffer (1X-PBS 
and 5% non-fat dry milk) the membrane was probed with affinity purified anti-DRA 
antibody (1:100 dilution; Dudeja lab) or anti GAPDH antibody (Sigma; 1:3,000 
dilution) in 1X-PBS and 2.5% non-fat dry milk overnight at 4°C. After washing the 
membranes were incubated with horseradish peroxidase-conjugated goat anti-rabbit 
Materials and Methods 
 
44 
IgG antibody (1:2,000 dilution) for 1 h at room temperature and washed for 30 min 
with agitation, during which the wash buffer was changed every 5 min followed by 
ECL (enhanced chemiluminescence, from Bio-Rad, Hercules, CA) detection (Kumar et 
al., 2014).  
4.5. Immunofluorescence staining (I, II) 
Mice were euthanized by CO2 inhalation and colons were excised. Colon samples were 
fresh frozen and embedded in Optimal Cutting Temperature compound (OCT) (Sakura 
Finetek, Netherlands). Sections of colonic tissue from K8-/-, K8+/- and K8+/+ mice were 
fixed with 4% paraformaldehyde in PBS for 15 minutes at room temperature and 
permeabilized using 0.5% NP-40 in PBS for 5 minutes, followed by blocking in 2.5% 
NGS (Normal Goat Serum) for 120 minutes at room temperature. Sections were then 
incubated with 1% NGS containing anti-DRA (1:100) and anti-villin (1:100, Abcam) 
antibody for 60 min. After washing with 1% NGS, sections were incubated with 
secondary antibodies, Alexa Fluor 488-conjugated goat anti-rabbit IgG and Alexa 
Fluor 568-conjugated goat anti-mouse IgG for 60 minutes and then mounted with 
Slowfade Gold antifade with DAPI reagent (Invitrogen) using cover slips. Edges of the 
coverslip were sealed using quick dry nail enamel. Sections were imaged using a Carl 
Zeiss LSM 510 laser-scanning confocal microscope at 20x magnification (Kumar et 
al., 2014). Images for MPO and DHE stainings were obtained by using Leica TCS SP5 
Matrix confocal and DM IRBE (inverted) immunofluorescence microscopes 
respectively. Histological sections stained by H&E were imaged by using AxioVert 
200M microscopes. 
4.6. RT-PCR Primers  
Table. 3. List of primers used in RT/PCR. (I, II) 
Protein Forward Reverse 
β-Actin 5'-TGG CTC CTA GCA CCA TGA AGA-3' 5'-GTG GAC AGT GAG GCC AGG AT- 3' 
K7 5'-GGA GAT GGC CAA CCA CAG-3' 5'-GGC CTG GAG TGT CTC AAA CTT-3' 
K8 5'-TGA ATT TGT CCT CAT CAA GAA GG-3' 5'-GGA TCT CCT CTT CAT GGA TCT G-3' 
K18 5'-AGA TGA CAC CAA CAT CAT CAC AAG G-3' 5'-CTT CCA GAC CTT GGA CTTCCT-3' 
K19 5'-TGA CCT GGA GAT GCA GAT TG-3' 5'-CCT CAG GGC AGT AAT TTCCTC-3' 
K20 5'-AGC TGA GAC GCA CCT ACC AG-3 5'-TGC GCT CCA GAG ACT CTT TC-3' 
K23 5'-TCA TGA AGA AAC GCC ATG AG-3' 5'-CCT TGA AGT CAC TCG GCA AG-3' 
DRA 5′-TGGTGGGAGTTGTCGTTACA-3′ 5′-CCCAGGAGCAACTGAATGAT-3′ 
PAT-1 5′-GAAATGGAGCTGCAGAGGA-3′ 5′-GCT GGAGCAGAAGAGAATGG-3′ 
NHE-3 5′-GGCCTTCATTCGCTCCCCAAG-3′ 5′-ATGCTTGTACTCCTGCCGAGG-3′ 
GAPDH 5′-TGTGTCCGTCGTGGATCTGA-3′  5′-CCTGCTTCACCACCTTCTTGAT-3′  
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4.7. Antibodies 
4.7.1. Primary Antibodies 
Table. 4. List of primary antibodies used for immunostaining and western blotting. The 
table provides information regarding antibody concentration, supplier information and their use 
in different methods. 
Antigen Antibody Conc. 
WB/IHC 
Supplier Application Used in 
K8 Troma I 1:100000 
/1:1500 
Hybridoma bank, USA WB, IHC I, II 
K19 Troma III 1:1000    
/1:100 
Hybridoma bank, USA WB, IHC I 
K18 Troma II 1:5000    
/1:100 
Hybridoma bank, USA WB, IHC I 
K7 RCK 105 1:300      
/1:10 
Progen, Germany WB, IHC I 
K20 IT-Ks 20.10 1:500      
/1:30 
Progen, Germany WB, IHC I 
Desmoplakin Anti-desmoplakin 1&2 Ready to 
use 
Progen, Germany IHC I 
Tubulin mouse anti-tubulin 1:200 Sigma, Germany WB I 
Caspase rabbit anti-caspase-7 1:1000 Cell signallling, USA WB I 
Caspase anti-cleaved caspase-7 1:1000 Cell signallling, USA WB I 
Hsc70 Anti Hsc70 1:1000 Stressgen, Canada WB I 
MPO anti-MPO Rabbit 
polyclonal Ab-1 
1:50 Thermo Scientific, 
USA 
IHC I, III 
DRA Anti-DRA Rabbit 
affinity purified 
1:100 Dudeja lab, USA IHC II 
Villin Anti-Villin mouse 
monoclonal 
1:100 Abcam, USA IHC II 
NHE3 Anti-NHE3 mouse 
monoclonal 
1:100 Abcam, USA IHC II 
*  WB: western blot; IHC: immunohistochemistry  
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4.7.2. Secondary Antibodies 
Table. 5. List of secondary antibodies used for immunostaining and western blotting. The 
table provides information regarding antibody concentration, supplier information and their use 
in different methods. 
Antibody Conc. Supplier Application Used in 
Alexa 488 goat anti-mouse 1:200 Invitrogen, USA IHC I, II 
Alexa 488 goat anti-rat 1:200 Invitrogen, USA IHC I 
Alexa 488 goat anti-rabbit 1:200 Invitrogen, USA IHC I 
Alexa 488 donkey anti-rabbit 1:200 Invitrogen, USA IHC III 
Alexa Flour 568 goat anti-mouse 1:500 Invitrogen, USA IHC I, II 
Rabbit anti-mouse HRP 1:5000 GE Healthcare, UK WB I 
Horse anti-rabbit HRP 1:1000 Cell signaling, USA WB I 
Donkey anti-rat HRP 1:25000 GE Healthcare, UK WB I 
4.8. Methods 
Table. 6. List of different methods used in PhD thesis. 
 
Name Publication 
Immunoflourosence staining I, II, III 
Bright field microscopy I, II, III 
Immunoflouroscence microscopy I, II, III 
Confocal microscopy I, II, III 
In vivo imaging I, III 
In situ imaging III 
Ex vivo imaging III 
Histology  I, III 
PCR I, II, III 
RT-PCR I, II 
Microarray, Ex-vivo colon culture Thesis 
SDS-PAGE I, II 
Western blot I, II 
High salt extraction, BrdU labeling I 
Isolation of lamina propria cells II 
Isolation of peritoneal cells I 
Induction of DSS colitis, Flow cytometry I, III 
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4.9. Reagents 
Table. 7. List of different reagents used in this PhD thesis showing supplier information 
and their usage in different methods.   
Reagent Supplier Application Used in 
DAPI Invitrogen, USA Immunohistochemistry I 
DRAQ-5 Cell signaling, USA Immunohistochemistry I, III 
TOTO-3 Invitrogen, USA Immunohistochemistry I, III 
Hematoxylin and Eosin Sigma-Aldrich, USA Tissue staining I, III 
Triton X-100  Sigma-Aldrich, USA High salt extraction I, III 
1X protease inhibitor mix Roche, Germany High salt extraction I 
EDTA Sigma-Aldrich, USA High salt extraction I 
DNase I enzymes Promega, USA RT-PCR I, II 
RNA later Qiagen, Netherlands RT-PCR I, II 
transcription kit Promega, USA RT-PCR I, II 
KAPA probe Fast ABI 
Prism qPCR mix 
Kapa Biosystems, 
USA 
RT-PCR I, II 
L-012 Wako Chemical,  
Germany 
In vivo, in situ and ex vivo 
imaging 
I, III 
Optimal Cutting 
Temperature compound 
Sakura Finetek, 
Netherlands 
Immunohistochemistry I, III 
Hank’s buffered saline 
solution 
Sigma-Aldrich, USA Lamina propria cells 
isolation 
I, III 
BrdU BD Pharmingen Immunohistochemistry I 
Borax solution Sigma-Aldrich, USA Immunohistochemistry I 
H2O2 Sigma-Aldrich, USA Lamina propria cells 
isolation 
I 
Dextran sulphate sodium TdB consultancy, 
Sweden 
Chemical models for 
colitis 
I, III 
Collagenase VIII Sigma-Aldrich, USA Flow cytometry I 
CD-FITC Immunotools, 
Germany 
Flow cytometry I 
Anti-CD49d-PE Immunotools, 
Germany 
Flow cytometry I 
Anti-L-selectin Immunotools, 
Germany 
Flow cytometry I 
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4.10. Statistical analysis (I, II, III)  
Mann-Whitney U (non-parametric data or data without normal distribution) and 
Student’s T test (parametric and data with normal distribution) were used for two-
group comparisons, whereas Bonferronis post hoc test (non-parametric data or data 
without normal distribution) or One-way ANOVA (parametric and data with normal 
distribution) was used for comparisons of three or more groups.  Survival data was 
analyzed by using the Kaplan-Meier test. The average ± SEM is shown in all figures 
and all p values < 0.05 were considered as significant. Graph Pad Prism and Excel 
software were used for statistical analysis. 
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5. RESULTS AND DISCUSSION 
5.1. Characterization of the baseline colonic phenotype of K8+/- mice as a 
possible model to address the roles of keratins in the intestine. (I) 
5.1.1. K8+/- mice have lower levels of keratins which are normally distributed in 
colonic epithelium with the exception of K7.  
In order to elucidate the effect of the absence of one KRT8 allele in K8+/- mice in terms 
of amount of keratins, the mRNA and protein levels of colonic keratins, i.e. type II 
(K7, K8) and type I (K18, K19, K20), were evaluated. In contrast to other colonic 
keratins, K8 mRNA levels were found to be decreased up to 50% as compared to the 
K8+/+ colon. Expectedly, the K8 protein levels were also decreased by 50% in these 
mice. Interestingly, the protein levels of other colonic keratins, i.e. K7 and K18, were 
significantly decreased. K19 and K20 protein expression was decreased to less extent 
(Fig.1, I) while mRNA levels of K7, K18, K19, K20 and K23 were found to be 
unaltered. This finding implies that colonic keratins are regulated at the post-
transcriptional level and filament assembly and stabilization requires K8 type I protein 
for making a dimer with its type II keratin protein partner (Coulombe and Omary, 
2002; Omary et al., 2009). Microarray assay was performed to identify the colonocyte 
genes that are differentially expressed in response to lower levels of keratins in K8+/- 
mice. These experiments did not show any upregulation or downregulation of K type II 
mRNA in K8+/- mice as compared to K8+/+ colonic crypt scrapings (not shown). Type 
II K8 and Type I K19 were the main colonic Ks found in high salt extraction. Ks have 
unique features of compensating each other in some instances (Coulombe and Omary, 
2002). However, no compensatory K protein was detected in high salt extracts.  
Immunofluoroscence staining did not only confirm the decreased amount of keratins in 
K8+/- colon but also revealed a normal keratin-distribution on the crypt-brush border 
axis with the exception of K7 (Fig. 2, I).  Small amount of K7 was expressed in the 
apical compartments of K8-/- colonic crypts,  which is quite predictable as type I 
keratins (K18, K19, K20), which are present at low levels in the K8-/- colonic crypts 
required a type II partner to make the filament. This indicates that K7 compensates for 
the absence of K8 in the cells close to the luminal region. The apical membrane is of 
great importance in maintaining the simple epithelia of the small intestine (Ameen et 
al., 2001). Like K8+/- mice, K7+/- mice have been shown to have 50% decreased K7 
mRNA and protein levels in bladder epithelium. Like K8-/- colon, mRNA levels of 
other keratins in the K7-/- bladder were found at the same levels as in K7+/+ (Sandilands 
et al., 2014). Moreover, slightly increased K20 mRNA has been detected in the K7-/- 
bladder. The K8-/- colon has slightly higher but not significant K20 mRNA levels as 
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compared to K8+/+. Our novel data based on colon studies indicate that the amount of 
K8 is crucial in regulating the protein levels of the other SEKs in the intestine. There is 
a clear dose dependent effect of keratin levels seen in transgenic mice, i.e. K8-/- < K8+/- 
< K8+/+, which can be used for further mechanistic studies to reveal the role of 
intestinal keratins.  
5.1.2. K8+/- mice exhibit a colonic phenotype. 
To characterize the phenotype of K8+/- mice, the K8+/- baseline morphology was 
studied by hematoxylin and eosin staining of colon sections and by measuring the crypt 
length (Fig. 3, I). It was observed that K8+/- mice have significantly thicker epithelium, 
as compared to K8+/+ mice. This increased thickness may be caused by increased 
epithelial proliferation. An increased BrdU staining in K8+/- colonic crypts confirmed a 
mild hyperproliferation of colonocytes in these mice (Fig. 4, I). The K8-/- mice develop 
colonic hyperplasia (Baribault et al., 1994; Baribault et al., 1993). However, K8+/- 
crypts were not very long as in K8-/- mice but still significantly longer than K8+/+ 
crypts, indicating an intermediate colonic phenotype. Unlike K8+/-, K7+/- mice do not 
show any kind of hyperplasia in the bladder or any other epithelium, although K7-/- 
mice show hyperproliferation in the bladder epithelium (Sandilands et al., 2014). In 
contrast to K8-/- colon which show decreased apoptosis (Habtezion et al., 2011), K8+/- 
colon show normal apoptotic rate. To our knowledge, the K8+/- mouse could be used as 
model which has epithelial hyperproliferation but normal rate of apoptosis suggesting 
the importance of the amount of K8 in the colonic crypts for the normal intestinal 
epithelial cell proliferation. 
It is obligatory for tissue homeostasis to keep a balance  between cell proliferation and 
apoptosis. Keratin function has been associated with proliferation and cell cycle (Pan et 
al., 2013). Increased proliferation has been seen in breast cancer cells after keratin 
knockdown and keratin over expression leads to decreased proliferation (Iyer et al., 
2014). K17 has been shown to regulate the protein synthesis and cell size during 
wound healing after phosphorylation and binding with 14-3-3 to initiate mTOR activity 
in keratinocytes (Kim et al., 2006). In terms of cell type context, the 14-3-3 may 
impact cell cycle associated regulators, i.e. Cdc25, in Xenopus eggs (Margolis et al., 
2006). K5 and K14 also perform the key role of maintenance of cell proliferation via 
phosphatidylinositol 3-kinase (PI3)/Akt-mediated cell proliferation and/or Notch1-
dependent cell differentiation (Alam et al., 2011). In contrast to decreased Akt kinase 
activity in the K17-/- mouse and K14 silenced keratinocytes, K8 and K18 ablation leads 
to increased Akt kinase activity in hepatocytes (Alam et al., 2011; Galarneau et al., 
2007; Kim et al., 2006).  The KtyII-/- mouse model lacking all type II keratins shows 
depressed mTORG1 activity and reduced protein synthesis besides having embryonic 
lethality and mistargeting of GLUT-1 and GLUT-3 transporters (Vijayaraj et al., 2009). 
Epithelial-to-mesenchymal transition (EMT) is known to lack keratin expression but 
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has high vimentin expression. K8 and K18 silencing leads to increased migration and 
invasiveness of epithelial cancer cells (Fortier et al., 2013). In contrast, a recent study 
using a novel lung cancer model has revealed that EMT does not directly depend on 
the keratin cytoskeleton but does rely on the changes in signaling pathways that results 
in alterations in keratins expression and organization (Konig et al., 2013). The colon 
cancer cells have decreased expression of K8 and K20, which suggests that EMT of 
cancer cells with higher metastatic potential eventually results in a decrease in the 
patient survival (Knosel et al., 2006). The exact mechanism of hyperproliferation in 
K8+/- mice is currently unknown and there is a need for future mechanistic studies to 
understand the possible link between hyperproliferation and the low levels of keratins 
in intestine.  
5.1.3. In contrast to K8-/- mice which show spontaneous colitis, K8+/- mice have no 
signs of intestinal inflammation.  
In contrast to the spontaneous Th2 mediated-colitis observed in K8-/- mice (Baribault et 
al., 1994; Habtezion et al., 2005), K8+/- mice do not show any obvious signs of colitis. 
However, the presence of hyperplasia led us to evaluate the inflammatory status of 
K8+/- mice. Myeloperoxidase (MPO) is an enzyme which is secreted by neutrophils at 
the site of inflammation and MPO staining on tissue sections is a widely used marker 
of inflammation (Loria et al., 2008). MPO staining of colon samples revealed no 
differences in the inflammation status between the K8+/- and K8+/+ mice. In addition, 
we used a novel in vivo imaging method to monitor oxidative stress in K8+/- mice. This 
method uses a chemiluminescent probe, L-012, with a high sensitivity for RONS 
(Asghar et al., 2014; Kielland et al., 2009). K8+/- mice showed similar amount of L-012 
signals as K8+/+ mice, which was in clear contrast to the high signals found in K8-/- 
mice (Fig.5, I). These findings were correlated by histological evaluations showing no 
infiltrating leukocytes or neutrophils in K8+/- and K8+/+ colon tissue (Fig. 3, I). We also 
performed FACS analysis to further determine the inflammatory status of K8+/- colon. 
We found that in contrast to colonic T-cells of K8-/- mice, those of  K8+/- mice were 
comparable to cells present in K8+/+ colon in terms of their number (Fig. 9), percentage 
of naïve (L-selectin positive) to effector T-cells (L-selectin negative) and their integrin 
α4 expression (Fig. 5, I). In K8-/- mice the number of colonic lamina propria (LP) T-
cells was dramatically increased and they displayed a Th2 type inflammatory cytokine 
profile. Similar to several other murine colitis models (Connor et al., 1999), the amount 
of the gut-homing molecule alpha4beta7 integrin was increased in K8-/- LP T-cells and 
K8-/- cells aberrantly expressed the receptor for L-selectin, which is important in the 
initial activation and trafficking of lymphocytes to the LP. Other colitis models, such 
as G (alpha) i2-deficient mice which display a Th1-type UC-like disease, similarly 
expressed increased levels of alpha4beta7 integrin and showed a large increase in 
memory (L-selectin-low) CD4+ T-cells in the LP (Hornquist et al., 1997). In contrast 
to the shortened K8-/- colon (Baribault et al., 1994), the K8+/- colon length was not 
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different from that of K8+/+ mice (Supplemental Table 2, I). Thus, from this data we 
concluded that K8+/- mice display a mild but significant colonic phenotype 
characterized by increased crypt length and thicker epithelium, but no inflammation. 
 
Interestingly, our microarray assays comparing gene expression patterns of K8+/- and 
K8+/+ colonocytes revealed that Egln3 which acts as a negative regulator of the NF-κB 
pathway (Fu and Taubman, 2013) was slightly upregulated in K8+/- mice. Similarly, the 
expression of Lgals 9 and Psmb9, which are known to be positive regulators of the NF-
κB pathway (Hensley, 2010; Kempe, 2005) was found downregulated. The expression 
of none of these genes was altered in K8-/- mice which exhibit colonic inflammation 
(not shown). RT-PCR experiments confirmed the decreased levels of Psmb9 mRNA in 
the K8+/- mice as compared to K8+/+ mice which were detected by microarray assays 
(Fig. 10). Based on these findings, we hypothesize that a defect in the NF-κB pathway 
may serve as the reason for the colonic hyperproliferation but lack of colonic 
inflammation in K8+/- mice. Further mechanistic studies are needed to explore these 
findings in more detail and to reveal the exact mechanism causing the phenotypes 
observed.  
 
Figure 9. K8+/- and K8+/+ lamina propria exhibit a similar number of T cells. 
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Table 8. Microarray analysis reveals that certain genes involved in the NF-ΚB pathway 
are downregulated in K8+/- colon. 
Symbol Fold 
change 
P-Value Protein Function Reference 
Egln3 1.592 0.0002 Egl nine 
homolog 3 
negative regulator of 
the NF-κB pathway 
(Fu, 2013) 
Lgals9 -2.074 0.0086 galectin-9 positive regulator of 
the NF-κB pathway 
(Kempe, 2005) 
Psmb9 -1.812 0.0091 proteasome 
subunit 
beta type-9 
Antigen processing 
and presentation  / 
activation of  NF-κB 
pathway 
(Hensley, 2010) 
 
Figure 10. RT-PCR confirms decreased mRNA levels of PSMB9 in the K8+/- colon found 
in the microarray analysis. Total colon RNA was isolated from colon epithelia obtained by 
scraping the mucosa with a microscope slide. β-actin was used as housing keeping gene.  
5.2. K8+/- mice have an increased susceptibility to experimental colitis.  
(I) 
To test our hypothesis that the amount of keratins matters for protection during colonic 
stress, we evaluated the susceptibility of K8+/- mice, which have reduced levels of 
keratins, to experimental colitis. We used an established chemical model of colitis, 
DSS to induce acute and chronic colitis in K8+/- mice by using different doses of DSS, 
i.e. 5%, 3%, 2.5% and 2% in autoclaved drinking water followed by different recovery 
periods, i.e 7 days for acute and 14 days per cycle for chronic inflammation. DSS 
causes epithelial damage and results in a robust inflammatory response (Breynaert et 
al., 2013; Burisch et al., 2013; Wirtz et al., 2007). Five percent DSS in drinking water 
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for 7 days followed by regular water for 3 days resulted in significant  body weight loss 
in K8+/- mice along with development of bloody diarrhea and low survival rate as 
compared to K8+/+ mice (Fig. 6, I). Similarly, 3% DSS treatment  for 5 days followed 
by drinking water  up to day 12, resulted in no difference in body weight loss, 
however, K8+/- mice showed more signs of diarrhea and a higher disease activity index 
(DAI) score as compared to K8+/+ mice (not shown). In another experiment, colitis was 
induced in K8+/+ and K8+/- mice by 2% DSS for 7 days followed by regular water 
applied for 5 days. Treated mice were analyzed for body weight change, stool 
consistency, L-012 signals, and histological alterations after 12 days. K8+/- mice 
showed a trend of higher DAI score on day 8 (Fig.11 A). Histology scoring revealed 
that K8+/- mice showed a trend towards loss of epithelium and crypts as compared to 
K8+/+ mice (Fig.11 C, E). K8+/- mice showed peak L-012 signals (Fig.11 B) indicating 
DSS induced inflammation on day 2, day 4 and day 8, while K8+/+ mice showed their 
peak signals on day 5 showing an early onset of DSS induced colonic inflammation in 
K8+/- mice. However, there was no significant difference in colon length between K8+/+ 
and K8+/- mice (Fig. 11 D). In order to investigate the recovery period in more detail, 
we induced chronic colitis with two cycles of one week 2.5% DSS administration 
followed by two weeks of autoclaved drinking water. In this setup K8+/- mice showed 
higher DAI score with higher histological damage than K8+/+ mice (Supp. Fig. 3, I). 
Therefore, it is concluded that K8+/- mice are more susceptible to DSS-induced colitis 
and are slower in recovery than K8+/+ mice. These findings support the significance of 
the colonic keratin amount for stress protection.  
Cytoprotection from stress is a characteristic feature of keratins (Pan et al., 2013; 
Pekny and Lane, 2007; Toivola et al., 2010). Our finding of increased susceptibility of 
K8+/- mice to DSS induced colitis further strengthens the model of a cytoprotective role 
of keratins in response to colonic stress. K8+/- mice showed delayed recovery from DSS 
damage, which indicates the importance of keratins not only in protection from stress 
but also in recovery from stress. It is well known that keratins are upregulated up to 
many folds during different kinds of stress and that constitutive and de novo keratin 
RNA and protein synthesis are the reasons for keratin upregulation. However, 
hyperproliferation of a particular cell type also leads to keratin upregulation in 
response to injury. For instance, bile duct proliferation leads to increases in the K19 
levels (Toivola et al., 2010). The increased sensitivity of K8+/- mice to colonic stress 
may be linked to the colonic hyperproliferation in these mice. However, the exact 
mechanism by which keratins play this critical role is not known yet and this link has 
not been comprehensively studied in other models. Although DRA-/- mice have been 
shown to develop hyperplasia (Schweinfest et al., 2006), further studies are needed to 
find out the keratin-ion transport link. On the other hand, Wnt antagonist DKK-/- mice 
showed hyperplasia due to increased proliferation which, in turn, was thought to 
protect mice from DSS damage and help in recovery (Koch et al., 2011). This indicates 
the ambiguity of the pathways. It is not clear whether keratin mutations predispose 
individuals to IBD (Owens et al., 2004; Tao et al., 2007), although keratin mutations in 
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some patients have been reported to predispose the carriers to liver disease. A recent 
study showed disruption of the intestinal barrier function by K8 and 18 mutations in 
colonic cell cultures (Zupancic et al., 2014). It has been shown that an additional stress, 
such as alcohol or drugs, in patients carrying keratin mutations caused potential 
damage to liver leading to liver diseases (Omary, 2009). Therefore, the K8+/- mouse 
with its mild colonic phenotype but increased susceptibility to the additional stress of 
DSS, supports a similar predisposition to stress. In contrast to the K8-/- model which 
exhibits inflammation interfering with many other processes, and to models 
overexpressing keratin mutations which cannot be used to study protective roles of 
keratins due to their significantly increased amounts of colonic keratins (Ku and 
Omary, 2006), the K8+/- mouse should be a valuable tool for studying the role of 
keratins in the intestine. 
 
Figure 11. K8+/- mice display a non-significant trend of increased susceptibility to 2% DSS 
experimental colitis. Colitis was induced in K8+/+ and K8+/- (n=8) mice by 2% DSS for 7 days 
followed by regular water for 5 days. Treated mice were analyzed for body weight change, 
bleeding and stool consistency as disease activity index (A), L-012  signals (B), colon length 
(D), and histology on day 13 (C,E). The early onset of colitis in K8+/- mice was shown by their 
peak L/012 signals on day 2, day 4 and day 8. On the other hand K8+/+ mice showed their peak 
signals on day 5. Increased crypt length and inflammation was seen in K8+/- mice compared to 
K8+/+ counterparts. 
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5.3. Keratins in ion transport in the intestinal epithelia. (II) 
5.3.1. K8-/- mice display downregulation of DRA mRNA in the colon.  
The diarrheal phenotype of K8-/- mice is characterized by decreased short circuit 
current and net sodium absorption associated with net chloride secretion in the distal 
colon (Toivola et al., 2004a). However, paracellular transport and tight junction 
permeability are as normal in the K8-/- as in the  K8+/+ distal colon (Toivola et al., 
2004a). The membrane-proximal markers H, K-ATPase-and F-actin are patchy while 
AE1/2 protein is redistributed and its levels are increased. ENaC protein is 
redistributed (Toivola et al., 2004a). K8-/- enterocytes have been shown earlier to 
exhibit anomalous apical membrane proteins including alkaline phosphatase, sucrase 
isomaltase and CFTR, while the K8-/- colon was shown to have normal polarized 
expression of CFTR (Ameen et al., 2001). A recent study has shown that K18 binding 
to CFTR increases its surface expression by accelerating CFTR apical recycling (Duan 
et al., 2012). The same study also suggested K8, K18 and K19 as modifier genes for 
CF (Duan et al., 2012). The K8+/- colon, which expresses 50% less keratins compared 
to the K8+/+ colon shows an intermediate ion transport, short circuit current and a 
proliferation phenotype, but lacks  inflammation (Asghar et al., 2015; Toivola et al., 
2004a). The K8-/- small intestine appears normal although mistargeting of epithelial ion 
transporters have been reported (Ameen et al., 2001). The effectiveness of ion transport 
as a function of keratin levels was assessed in K8+/+, K8+/- and K8-/- mice by examining 
the distribution and expression levels of the chloride channel DRA, the anion 
exchanger AE1/2, the Na-transporter ENaC gamma and the Na+/H+ exchangers NHE1 
and NHE3, as these potential candidate transporters could account for the abnormality 
in Na+ and Cl- transport. No differences in mRNA levels of CFTR (Fig. 12), NHE3 
(Fig. 13) and PAT-1 (Fig. 14) were observed in cecum and colon scrapings from  
K8-/- or K8+/- mice compared to K8+/+ mice. However, the mRNA levels of the chloride 
transporter DRA were decreased 3-4 fold in the K8-/- caecum, proximal and distal 
colon compared to K8+/+. Interestingly, DRA mRNA levels were unaltered throughout 
the K8+/- and K8-/- small intestine (Fig. 1. II).  This finding matches with previous study 
showing that K8+/- enterocytes have a normal distribution of membrane markers 
(Ameen et al., 2001). This is possibly due to the fact that PAT-1 is the main chloride 
transporter in the small intestine, while DRA predominantly controls chloride transport 
in colon (Farkas et al., 2010; Musch et al., 2009; Walker et al., 2008; Wang et al., 
2002).  DRA levels may be associated with K8 via microflora and short chain fatty 
acids (SCFA). K8-/- mice have less bacteria (Habtezion et al., 2011) but have increased 
levels of SCFA in the colon (Helenius et al., 2015). The SCFA transporter, MCT1 is 
upregulated by butyrates. Therefore, DRA levels may be regulated by K8 indirectly. 
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Figure 12. Unaltered mRNA levels of CFTR in the ileum, cecum, proximal and distal 
colon. The mRNA levels of CFTR were determined from epithelial scrapings isolated from 
ileum (A), cecum (B), proximal (C) and distal colon (D) of the K8+/+, K8+/- and K8-/- mice (n=4). 
One-way ANOVA with Tukey’s test was used for statistical analysis. P < 0.05 or less was 
considered statistically significant. P values for ileum, cecum, proximal and distal colon were 
0.5, 0.06, 0.05 and 0.10 respectively.  
5.3.2. Reduced levels of DRA protein in K8-/- mice.   
Western blot analysis showed that DRA protein levels were significantly reduced in the 
K8+/- proximal colon, while almost abolished in K8-/- proximal and distal colon, 
suggesting an involvement of K8 in DRA regulation. K8+/- mice showed normal DRA 
mRNA levels; however, the DRA protein was significantly reduced in proximal colon 
whereas cecum and distal colon showed a trend of non-significant decrease protein 
levels (Fig. 2, II). Together these findings suggest an involvement of K8 in DRA 
mRNA and protein expression. This finding led us to hypothesize that the aberrant 
intestinal ion transport found in K8+/- mice may be due to lower amount of keratins.  
Results and Discussion 
 
58 
 
Figure 13. Unaltered mRNA levels of NHE3 in the ileum, cecum, proximal and distal 
colon. The mRNA levels of NHE3 were determined from epithelial scrapings isolated from 
ileum (A), cecum (B), proximal (C) and distal colon (D) of the K8+/+, K8+/- and K8-/- mice (n=4). 
One-way ANOVA with Tukey’s test was used for statistical analysis. P < 0.05 or less was 
considered statistically significant. P values for ileum, cecum, proximal and distal colon were 
0.08, 0.07, 0.08 and 0.6 respectively.  
5.3.3. NHE3 has normal distribution and DRA is lost in in K8-/- colonic crypts.     
Immunofluorescence staining and confocal microscopy were performed to find out the 
cellular location of the colonic DRA as a function of K8. Our results showed that DRA 
was abolished in the apical membrane of the K8-/- distal colon as compared to K8+/- and 
K8+/+ mice, while villin which is a marker for microvilli was normally distributed (Fig. 
15; Fig. 3, II). Interestingly, K8+/- distal colon showed patchy apical staining for DRA 
(Fig. 3, II). This finding led us to speculate the role of K8 in controlling DRA levels. 
The NHE3 protein was also found to be normally distributed in colonic crypts of K8-/- 
mice (Fig. 4, II).  
It was concluded that the dramatic loss of DRA in colon and cecum of K8-/- mice was 
likely responsible for the chloride transport defect. The milder ion transport phenotype 
in K8+/- colon might be related to DRA, suggesting a role for K8 in the regulation of 
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DRA expression and targeting. The patchy DRA staining in the K8+/- distal colon is 
interesting and future studies may provide a clue about how the amount of keratins 
regulates DRA levels in the colon.  
5.3.4. K8 knock down by siRNA leads to reduced DRA expression in Caco-2 cells.   
Since the K8-/- mouse has inflammation (Habtezion et al., 2005) and DRA expression 
has also been shown to be reduced during inflammation (Gill et al., 2007; Saksena 
et al., 2010), it was not clear whether the reduced DRA expression in K8-/- colon 
was either due to K8 deficiency or inflammation. To study this, we first performed 
immunostaining on sections from distal colon of 1-2 day old mice as K8-/- mice 
develop inflammation at the age of 2 weeks. To our surprise, we found that DRA 
was not expressed in these mice (not shown). We then used in vitro approaches to 
elucidate if the reduced DRA levels in the K8-/- mice were secondary to 
inflammation or, loss of K8 directly. K8 was silenced by using siRNA in Caco-2 
cells and the DRA expression was evaluated. Western blot analysis showed that the 
DRA expression was reduced 3-4-fold in K.8 silenced Caco-2 cells. Interestingly, 
K8 levels were also decreased 3-4 folds in response to K8 siRNA treatment in Caco-
2 cells. This suggests that DRA expression is modulated by keratins directly in an 
inflammation-dependent manner. (Fig. 5, II). This is the first evidence to our 
knowledge showing a direct effect of reduced keratin levels on DRA expression.  
The outcome of this study provides insight for future studies to explore the 
mechanism by which K8 regulates DRA expression. 
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Figure 14. Unaltered mRNA levels of PAT-1 in ileum and proximal colon. The mRNA 
levels of PAT-1 were determined from epithelial scrapings isolated from ileum (A) and 
proximal colon (B) of the K8+/+, K8+/- and K8-/- mice (n=4). One-way ANOVA with Tukey’s 
test was used for statistical analysis. P < 0.05 or less was considered statistically significant. P 
values for ileum, cecum and proximal colon were 0.3 and 0.08 respectively.  
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Figure 15. Immunofluorescence staining of distal colon shows the dramatic loss of DRA in 
K8-/- mice. (modified from Fig.3, III). Distal colon cryosections fixed with acetone at -20C 
were stained by using DRA Ab. The results  show  absence of DRA (green) in K8-/- distal colon 
apical membrane (B) as compared to normal staining in K8+/+ mice (A). Apical villin (red) was 
not altered and DAPI (blue) was used to stain the nuclei.    
DRA plays an important role in maintaining intestinal homeostasis in humans and 
mice. Mutations in the hDRA gene lead to the autosomal recessive disorder CLD 
(Hoglund et al., 1996; Makela et al., 2002). Like K8-/- mice, DRA-/- mice also have  
a diarrheal phenotype resembling CLD with upregulation of ion transporters 
(Schweinfest et al., 2006). NHE3-/- mice exhibit high DRA expression (Melvin et al., 
1999). Similarly, it has been shown in previous studies involving human UC patients 
and IL-10-/- mice that DRA expression is reduced in inflammation (Farkas et al., 
2010; Ku et al., 1999; Kuhn et al., 1993; Yang et al., 1998). Cell culture studies have 
shown that DRA was downregulated in response to IL1β and IFN γ (Saksena et al., 
2010; Yang et al., 1998). Reduced DRA levels have also been found in EPEC 
infection and DSS colitis (Gill et al., 2007; Xiao et al., 2014). It is speculated that K8 
may regulate DRA levels via STAT-1 pathway. 
Our studies reveal a novel link between K8 and DRA expression in the mammalian 
colon. K8-/- mice have decreased NaCl absorption but no change in paracellular 
permeability and ENaC mistargeting (Toivola et al., 2004a). In contrast, ENaC 
knockout mice do not develop diarrhea (Hummler and Vallon, 2005). Our studies also 
showed that NHE3 expression or targeting was not altered. Therefore, it is concluded 
that K8 inactivation leads to dramatic downregulation of DRA which is the main cause 
of diarrheal phenotype observed in K8-/- mice. 
A. B. 
K8
+/+
 K8
-/-
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5.4. Establishment of a novel in vivo imaging of colitis. (III) 
IBD is a complex disease and the early diagnosis may be challenging. There is a need 
to develop an easy and direct method for the specific and early diagnosis of colitis 
which could also be used for monitoring disease progression and/or treatment 
effectiveness, as current techniques analyzing mouse colitis have their own limitations 
(Becker et al., 2005; Mitsunaga et al., 2012; Mizoguchi, 2012; Mizoguchi and 
Mizoguchi, 2010; Moussata et al., 2010; Wirtz et al., 2007). The fourth aim of my PhD 
thesis was to establish a novel in vivo imaging method for colitis diagnosis. We 
evaluated the use of a luminol derivative, the chemiluminescent probe L-012, for in 
vivo imaging. L-012 has high sensitivity for detection of RONS (Daiber et al., 2004; 
Imada et al., 1999; Kielland et al., 2009).  
 
Figure 16.  In vivo imaging of murine colitis using L-012. 
Our data showed that in vivo imaging of RONS is able to detect the previously 
described chronic colonic inflammation in two genetic and one chemical model of 
colitis, i.e. K8-/-, NOD mice and DSS (Fig.1, 3, 4, III, Fig. 16). The L-012 signals 
correlated with ex-vivo imaging and histological evaluations (Fig. 2, III). MPO and 
CellRox staining of colon sections confirmed the inflammation K8-/- mice and L-012 
signals corresponding to the K8-/- inflammation correlated with a high MPO score 
(Fig.2, III). Due to its high specificity for RONS, L-012 is the only chemiluminescent 
probe that has been used for in vivo imaging of skin and arthritis disease models 
(Kelkka et al., 2012a; Kelkka et al., 2012b; Kielland et al., 2009; Zhou et al., 2012), 
which do not require deeper tissue penetration. However, organs like colon requires 
deep tissue imaging due their anatomical position. This bottle neck was solved by 
lipopolysaccharide manipulation of RONS (Kielland et al., 2009) besides correlating 
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with abdominal location of an NF-kB luciferin reporter in a systemic lupus model 
(Zangani et al., 2009). Unlike K8-/- mice, many IBD mouse models, e.g. IL-10 
knockout mice do not develop early spontaneous colitis but these mice develop colitis 
at the age of few months. L-012 imaging may be used to monitor the onset and 
progression of colitis in these models or to see the effect of a treatment (Mizoguchi, 
2012; Mizoguchi and Mizoguchi, 2010).  
We found that L-012 may be used as a probe to monitor the progression of 
experimental colitis and possibly for early detection of colitis in individual mice in the 
DSS model (Fig. 4, III). This was evidenced by the peak L-012 signals already on day 
4 in the 2% DSS model, while signs of colitis such as bloody stool or body weight loss 
were observed from day 6 and 7 onwards.  The L-012 signals were down to baseline 
levels on day 9 when the severity of colitis was highest, as indicated by histology (Fig. 
4, III). The lower L-012 signals are due to the damaged lamina propria and colonic 
epithelium in response to DSS treatment leading to the loss of RONS producing 
neutrophils (Murphy et al.; Ohtsuka and Sanderson, 2003; Pravda, 2005). In contrast to 
the genetic model of colitis, high variations in L-012 signals were seen among 
individual mice after receiving DSS treatment and in young untreated mice. These 
variations may be due to age dependent individual mouse immune system development 
and individual mouse response to DSS. As a matter of fact, quantitative imaging of 
RONS is challenging as they are also present in healthy colon and bursts are short-
lived (VanderVen et al., 2009). Although previous studies using ex vivo imaging of 
human biopsies showed increased luminol signals correlating with the colitis disease-
state  (Sedghi et al., 1993). 
 
Ex vivo and in situ imaging revealed that the main source of abdominal signals in K8-/- 
mice was distal colon (Fig. 5, III) as further validated by PET imaging using [18F] FDG 
(Fig.6, III). In vivo imaging also showed that the K8-/- rectal prolapses (Baribault et al., 
1994) had strong L-012 derived signals, further confirming the location of RONS in 
the colon of K8-/- mice, while K8-/- peritoneal cells had no L-012 chemiluminescence 
indicating that the abdominal signals are not derived from the peritoneum (Fig. 7, III). 
Careful analysis of L-012 data revealed that K8-/- mice had an ontogenic increase in L-
012 chemiluminescent signals corresponding to colonic inflammation. This correlates 
well with previous studies showing that 6-month-old K8-/- mice had higher colonic 
cytokine levels (Habtezion et al., 2005), increased risk for rectal prolapse (Baribault et 
al., 1994) and more auto-antibodies than 3-month-old K8-/- mice (Toivola et al., 2015).  
L-012 has no apparent toxic or adverse effects (Kelkka et al., 2012a; Kelkka et al., 
2012b; Kielland et al., 2009) as monitored by mouse health and appearance, even upon 
multiple consecutive administrations as seen in the control mice used during DSS 
colitis imaging experiment. The data suggests that in vivo imaging by using L-012 is as 
a novel method to study colitis in genetic and induced colitis models. Moreover, this 
probe may also be useful in studying the  susceptibility of genetic mice to DSS.  
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Recently, L-012 has been used to study the spatial and temporal aspects of 
inflammation in response to different diet in NOD mice. The whole gut imaging 
revealed increased RONS production in ileum of NOD mice highlighting the 
mechanistic towards diet-dependent regulation of diabetogenesis in type 1 diabetes 
(Emani et al., 2013). The use of L-012 should also aid in diminishing the number of 
mice used in experiments following colitis. Future development of chemiluminescent 
probes such as luminol derivatives with longer half-life or other RONS sensitive 
probes in combination with 3-dimensional imaging, or probes coupled with 
nanoparticles, would be useful in improving the quality of in vivo imaging and would 
make it possible to provide a better in vivo imaging modality for human use.  
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6. CONCLUDING REMARKS  
This work was initiated in November 2009 and at that time, the role of keratins in the 
simple epithelium of the colon had not been extensively studied. This thesis work is 
primarily focused on the role of the IFs of epithelial cells, the keratins, in intestinal 
health and diseases. We have investigated the intestinal phenotype of K8+/- mice, which 
express 50% less keratin as compared to K8+/+ mice and, thus, provide a novel model to 
study the functional significance of keratins in the intestine. Our findings are consistent 
with the fact that keratins are stress-protective proteins. In analogue, human individuals 
carrying keratin mutations are predisposed to several diseases. By using different 
colitis models and multiple imaging modalities, we have shown that decreased keratin 
levels in mice lead to altered ion transport, increased epithelial proliferation and 
susceptibility to experimental colitis, proposing that keratin amounts matter in 
intestinal health. We further investigated the role of keratins in intestinal ion transport 
and showed that the intestinal ion transport phenotype in K8-/- and possibly in K8+/- 
mice is due to dramatic loss of the main chloride transporter DRA. We also 
successfully established a novel in vivo imaging method for the early detection of 
colitis, which proved useful for genetic colitis models. The current thesis work 
provides new information about the structural and functional roles of keratins, 
particularly K8, in colitis and in the normal colon. This work is also significant for 
understanding the human diseases which are linked to keratin mutations. The outcome 
of this thesis work may also be helpful towards future development of diagnostics and 
treatment of colitis. In conclusion, this thesis does not only highlight the significance 
of K8 in the colon but also opens the door for future studies in order to find out the 
mechanism by which keratins regulate the intestinal homeostasis and ion transport in 
epithelia.  
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